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ABSTRACT  
   
Circular RNAs (circRNAs) are a class of endogenous, non-coding RNAs that are 
formed when exons back-splice to each other and represent a new area of transcriptomics 
research. Numerous RNA sequencing (RNAseq) studies since 2012 have revealed that 
circRNAs are pervasively expressed in eukaryotes, especially in the mammalian brain. 
While their functional role and impact remains to be clarified, circRNAs have been found 
to regulate micro-RNAs (miRNAs) as well as parental gene transcription and may thus 
have key roles in transcriptional regulation. Although circRNAs have continued to gain 
attention, our understanding of their expression in a cell-, tissue- , and brain region-
specific context remains limited. Further, computational algorithms produce varied 
results in terms of what circRNAs are detected. This thesis aims to advance current 
knowledge of circRNA expression in a region specific context focusing on the human 
brain, as well as address computational challenges.  
The overarching goal of my research unfolds over three aims: (i) evaluating 
circRNAs and their predicted impact on transcriptional regulatory networks in cell-
specific RNAseq data; (ii) developing a novel solution for de novo detection of full length 
circRNAs as well as in silico validation of selected circRNA junctions using assembly; 
and (iii) application of these assembly based detection and validation workflows, and 
integrating existing tools, to systematically identify and characterize circRNAs in 
functionally distinct human brain regions. To this end, I have developed novel 
bioinformatics workflows that are applicable to non-polyA selected RNAseq datasets and 
can be used to characterize circRNA expression across various sample types and 
diseases.  Further, I establish a reference dataset of circRNA expression profiles and 
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regulatory networks in a brain region-specific manner. This resource along with existing 
databases such as circBase will be invaluable in advancing circRNA research as well as 
improving our understanding of their role in transcriptional regulation and various 
neurological conditions. 
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CHAPTER 1 
INTRODUCTION 
 
1. Background 
The transcriptome of an organism refers to the set of all RNA molecules in a cell 
or a population of cells. Traditionally, the whole transcriptome was considered to be 
primarily composed of messenger RNAs (mRNAs), ribosomal RNAs (rRNAs) and 
transfer RNAs (tRNAs). However, more recently additional RNA species such as 
microRNAs (miRNA), piwiRNAs, and long non-coding RNAs (lncRNAs) have been 
characterized. Circular RNAs (circRNAs) represent one such recent addition to the whole 
transcriptome. CircRNAs are endogenous non-coding RNAs that form covalently closed 
continuous loops and are both highly conserved and abundant in the mammalian brain [1-
3]. Though circularization events in the RNA were reported in the 1970s and 1990s [4-6], 
they were disregarded as molecular artifacts formed as a result of aberrant splicing. 
However, with the advent of next generation sequencing technology coupled with the 
development of computational algorithms focused specifically on detecting these back-
splicing events, numerous circRNAs have been reported since 2012.  
Some of the key findings from these circRNA studies include (i) circRNAs 
exhibit cell type, tissue and developmental stage specific expression [3, 7]; (ii) they have 
no 5’-3’ polarity or polyadenylated tail, making them more stable than linear RNAs [2]; 
(iii) they exhibit evolutionary conservation between the mouse and human [2, 3]; (iv) 
they tend to have longer flanking introns (compared to non-circularized expressed exons) 
that are enriched with reverse complementary sequences, possibly aiding in their 
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biogenesis [2];  (v) in some cases, they exhibit higher expression than their cognate linear 
isoforms [1-3]; (vi) most exonic circRNAs are localized to the cytoplasm [1-3]; (vii) 
naturally occurring circRNAs are not associated with ribosome protected fragments, 
suggesting that they are not translated; however, engineered circRNAs designed with an 
internal ribosomal entry site (IRES) can be translated in vitro and in vivo [8, 9]. 
 
2. Biogenesis 
The majority of identified circRNAs are derived from exons, wherein a 
downstream splice donor is covalently linked to an upstream splice acceptor, to form a 
‘head-to-tail’ splice junction.  
Although the exact mechanism of circRNA biogenesis remains to be elucidated, a few 
possible mechanisms have been proposed:  
 
2.1 Lariat driven circularization 
When the middle exons are skipped during a linear splicing event, the spliced out 
intron lariat contains those skipped exons. If further splicing occurs within the lariat 
before its degradation, a stable circRNA enclosing the skipped exons may be generated. 
45% of the predicted circRNAs in [2] also exhibited exon skipping events, suggesting 
that RNA circularization could be correlated with exon skipping.  
2.2 Intron-pairing driven circularization 
Intronic motifs that flank the potential circRNA exons such as ALU repeats, 
complementary sequences or other RNA secondary structures could also aid in exon 
  3 
circularization.  In this model, exon skipping is not required since the complementarity of 
the flanking sequences brings the non-sequential donor acceptor pairs side by side [2].  
Apart from these, specific RNA-binding proteins (RBPs) have been reported to 
regulate circRNA biogenesis, such as quaking (QKI) and adenosine deaminase 1 
(ADAR1). QKI regulates circRNA formation during epithelial-mesenchymal transition in 
humans, and the insertion of synthetic QKI-binding sites into linear RNA induces exon 
circularization [10]. ADAR1 on the other hand suppresses specific circRNA expression 
by the adenosine-to-inosine (A-to-I) editing activity of ADAR1 on the duplexes formed 
between the circRNA flanking sequences. Furthermore, knockdown of ADAR1 
significantly up-regulates the expression of specific circRNAs, suggesting that ADAR1 
antagonizes circRNA expression [11]. 
Although the majority of reported circRNAs are derived from exons, special 
subtypes of circRNAs have also been observed. These include exon-intron circRNAs 
(EIcircRNAs), composed of both exonic and intronic sequences [12], circular intronic 
RNAs formed from eukaryotic spliceosomal introns [13], and tRNA intronic circRNA 
(tricRNAs) generated during pre-tRNA splicing [14]. 
 
3. Putative functions 
The abundance and evolutionary conservation of circRNAs suggests that they 
could have a potential role in cellular processes, the majority of which are still unknown. 
However, a few possible functions have been reported, including micro-RNA (miRNA) 
binding, mediation of protein-protein interactions and regulation of parental gene 
transcription [3, 6, 12, 15-19].  
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3.1 MicroRNA regulation 
MicroRNAs are 18 to 25 nucleotides long and are a class of non-coding RNAs. 
They are important regulators of gene expression and function by directly pairing to 3’ 
untranslated regions (UTRs) of their target mRNAs. Two exonic circRNAs, one from the 
mouse SRY gene [6, 15] and the other, human/mouse cirRS-7 (also known as CDR1as) 
[3, 16] have been shown to bind miRNAs. Further, photoactivatable-ribonucleoside-
enhanced crosslinking and immunoprecipitation (PAR-CLIP) experiments have been 
used to validate CDR1as binding to miR-7 effector protein argonaute (AGO) [3]. The 
circular Sry transcript harbors 16 miR-138 binding sites, while cirRS-7 has 74 miR-7 
binding sites. Notably, the cirRS-7 circRNA is highly expressed in human and mouse 
brain and acts as a sponge/inhibitor of miR-7, thus resulting in increased levels of miR-7 
targets [3]. Such miRNA binding competes with the binding of miRNAs to their linear 
transcript targets, thereby mitigating the effect of miRNA-mediated post-transcriptional 
regulation.  
3.2 Protein decoys 
CircRNAs could also act as decoys to RBPs, thereby impacting functions in 
which RBPs are involved. Recently, circRNA circ-Foxo-3 was found to form a ternary 
complex with cell cycle proteins cyclin-dependent kinase 2 (CDK2) and cyclin-
dependent kinase inhibitor 1 (p21). This interaction prevents CDK2 from interacting with 
cyclins A and E, which is required for cell cycle progression [19]. In addition, circ-Foxo3 
interacts with senescence response associated proteins such as ID1, E2F1, FAK and 
HIF1A and promotes cardiac senescence [18]. 
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3.3 Transcriptional and splicing regulation 
Some circRNAs have also shown the ability to regulate parental/host gene 
transcription. In a recent study, the EIcircRNA EIciEIF3J was found to interact with the 
U1 spliceosomal component and the promoter of EIF3J to enhance EIF3J transcription 
[12]. In a separate study, the interaction between the circular form of musclebind circMbl 
and MBL protein was found to modulate the splicing activity of MBL and regulate the 
pre-mRNA splicing of the host gene by competing with the canonical splicing machinery 
[17]. 
 
4. CircRNAs in brain and other tissue types 
Recent studies have reported preferential back-splicing of neural genes and an 
abundance of circRNAs in the mammalian brain. Rybak-Wolf et al. [20] analyzed human 
and mouse neuronal cell line data as well as published sequencing data from the 
ENCODE Consortium [21] to identify circRNAs. Their analysis revealed that circRNAs 
are highly abundant in the mammalian brain compared to other analyzed tissues such as 
lungs, heart, kidney, testis and spleen, with well conserved sequences across mouse and 
humans. They also found that circRNAs were up-regulated during neuronal 
differentiation and development, and highly enriched in synapses, independent of their 
corresponding linear isoform.  
In a separate study [22], analysis of RNA sequencing (RNAseq) data from mouse 
brain, liver, heart, lung and testis revealed that although circRNAs were present in all the 
examined tissues, their abundance was highest in the brain. Further, 20% of the protein 
coding genes in the brain were found to produce circRNAs. The study also found an 
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enrichment of circRNAs compared to their host linear transcripts in synaptosomes and 
microdissected neuropils from mouse hippocampal slices. Analysis of circRNA 
expression in developing cultured hippocampal neurons (stages: E18 - embryonic, P1 - 
early postnatal, P10 - postnatal at the beginning of synapse formation, and P30 - late 
postnatal) revealed an increase in circRNA levels during the P10 - P30 transition, 
corresponding to the time of synapse formation. Notably, the up-regulated circRNAs 
during this transition were mostly derived from host mRNAs that play a role in synaptic 
function such as Dlgap1 (DLG associated protein 1) and Homer1 (homer scaffolding 
protein 1). 
Various other tissue types including heart, colon, kidney, liver and lung, as well 
as glandular tissues such as the adrenal gland, mammary gland, pancreas and thyroid 
gland have also been examined and found to have varying abundances of circRNAs 
(Table 1.1) [23-26]. Apart from these, extracellular fluids such as plasma and serum have 
also been investigated [25]. The number of circRNAs detected from these studies has 
been summarized in Table 1.1. 
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Study Tissue type examined 
Number of 
Donors 
Number of 
circRNAs detected 
Ref 
Tan et al., 2016 Heart 12 15318 26 
Xu et al., 2016 Colon, heart, kidney, 
liver, stomach 
6 
8,120 28 
Xu et al., 2016 Adrenal gland, 
mammary gland, 
pancreas, thyroid 
gland 
4 
14,433 27 
Maass et al., 2017 Placenta 1 63 
 Maass et al., 2017 Umbilical cord 1 85 
 Memczak et al., 
2015 
Cerebellum 2 
6,289 25 
Memczak et al., 
2015 
Liver 2 
1,198 
 Memczak et al., 
2015 
Blood 2 
6,213 
 Maass et al., 2017 Plasma 1 57 27 
Maass et al., 2017 Serum 1 39   
Table 1.1: Summary of circRNA detection results in various tissue types 
 
5. CircRNAs in other species  
Apart from humans, circRNAs have also been observed in several other species, 
particularly mice [1-3, 20, 22, 27-29], across various studies. Some of the initially 
identified circRNAs were from the mouse SRY (sex determining region-Y) gene [6] and 
the DCC (Deleted in Colorectal Carcinoma) gene in human and rodent cells [5]. Other 
common model organisms used in circRNA studies include Drosophila melanogaster [7, 
30] and Caenorhabditis elegans (C. elegans) [3, 31]. Memczack et al. [3] were one of the 
first few to report circRNAs in other species, and identified 1,903 circRNAs in mouse 
sequencing data and 724 circRNAs in C. elegans, each with at least two independent 
junction spanning reads [3]. They also observed for the first time that in the nematode, 
some of the expressed circRNAs showed developmental stage specific expression. 
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6. CircRNAs in disease 
Recent evidence has suggested that circRNAs may have regulatory roles in the 
initiation and development of diseases.  
6.1 Alzheimer’s disease 
Given the high abundance of the miRNA miR-7 and its association with ciRS-7 in 
the human brain, Lukiw [32] studied the levels of ciRS-7 in Alzheimer’s affected brain 
cells from the CA1 hippocampal region. Using Northern blots and ribonuclease R (RNase 
R) treatment, his group observed that ciRS-7 levels were significantly reduced in AD 
brains, suggesting the existence of a dysregulated ciRS-7-miR-7 system in these samples. 
RNase R is a magnesium-dependent 3´-5´ exoribonuclease (enzyme that degrades RNA 
from the terminal nucleotides) that digests most linear RNAs but leaves behind lariat or 
circRNA structures. The study hypothesizes that due to the low abundance of ciRS-7, less 
regulation of miR-7 may down-regulate expression of AD associated targets such as 
ubiquitin protein ligase A, which is normally responsible for clearing up amyloid plaques 
in AD. However, functional studies still need to be performed to elucidate the role of 
ciRS-7 in AD.    
6.2 Glioblastoma 
In order to explore the expression profiles of circRNAs in glioblastoma 
multiforme (GBM), Zhu et al. [33] analyzed tumor tissues from five GBM patients and 
five normal brain samples. Their study revealed a total of 1,411 differentially expressed 
circRNAs in GBM patients, among which 206 were up-regulated and 1,205 were down-
regulated circRNAs. KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway 
analysis on the down-regulated circRNAs revealed that ErbB signaling pathway and 
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Neurotrophin signaling pathway were the most enriched. Further, circBRAF expression 
was found to be significantly higher in normal brain tissues compared to glioma tissues. 
Additionally, circBRAF was significantly lower in glioma patients with a higher 
pathological grade than those with lower grades. 
6.3 Acute lymphoblastic leukemia 
Salzman and colleagues hypothesized that local structural rearrangements in the 
human genome may contribute to the progression of human cancers [1]. In order to test 
this hypothesis, the authors performed RNAseq on rRNA depleted total RNA from the 
bone marrow of 5 children with acute lymphoblastic leukemia (ALL). They searched for 
transcripts with exons in a scrambled order. This analysis identified hundreds of genes 
with exon scrambling and these factors were estimated to comprise more than 10% of 
total transcript isoforms. Contrary to their hypothesis, they found that all the PCR-
verified exon scrambling events in leukemia samples were also present in HeLa cells and 
peripheral blood cells collected from the same patients, as well as in H9 human 
embryonic stem cells. This seemed to suggest that the splicing process that led to the 
formation of scrambled exons were active in both normal and malignant human cell 
types.  Of the two models considered to explain transcripts with scrambled exons, their 
statistical approach predicted that scrambled exons originated in a circRNA. To 
experimentally validate this finding, a panel of 9 isoforms across 6 genes with scrambled 
exons was tested for sensitivity to RNase R. The resistance of these transcripts to RNase 
R degradation supported their hypothesis that the majority of the scrambled transcripts 
were circRNAs.  
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6.4 Colorectal cancer 
Heyda et al. [34] looked for circRNAs in rRNA depleted RNAseq datasets from 
12 tumor tissues of colorectal cancer patients and their matched normal colon mucosa 
samples. Their analysis revealed an over-representation of significantly down-regulated 
circRNAs in the tumor samples. Further, they found that the ratio of circular to linear 
RNA isoforms was lower in tumor samples compared to normal colon samples and that 
this ratio correlated negatively with the proliferation index (percentage of Ki-67 positive 
cells; Ki-67 is a protein required for cellular proliferation). The negative correlation of 
global circRNA abundance to proliferation was validated in rRNA depleted RNAseq 
datasets from idiopathic pulmonary fibrosis samples, serous ovarian cancer cell samples 
and 13 normal human tissues. In all three, the expression level of MKI67 (Maker of 
proliferation Ki-67) was negatively correlated to global circRNA abundance.  
  
7. Circular RNA detection 
7.1 Biochemical enrichment of circular RNAs 
In 2010, Burd et. al [35] discovered a circRNA species, circular ANRIL 
(cANRIL), expressed at very low levels in Hs68 human fibroblast cell lines, and which 
correlated positively with the risk of atherosclerosis. Following this discovery, they 
developed an experimental protocol for circRNA enrichment, CircleSeq, wherein rRNA 
is first depleted from total RNA using RNase R, and high-throughput sequencing is 
performed on the RNA library [2]. Using this protocol, they enriched for circRNAs in 
human fibroblast cells and identified circRNAs using Mapsplice [36], a de novo splice 
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mapping algorithm. Notably, this enrichment step has also been successfully used by 
other groups to enrich for circRNAs [3, 24]. 
7.2 Computational tools for circular RNA detection 
In the last few years, various circRNA prediction algorithms have been developed 
in order to computationally detect circRNAs from RNAseq data. These algorithms can be 
classified into two broad categories based on their dependency on genome annotation: 
pseudo-reference-based and fragment-based strategies. In the pseudo-reference-based 
strategy, a pseudo reference comprised of all possible combinations of exon pairs is 
constructed. RNAseq reads aligning to these putative circRNA references are marked as 
potential circRNAs. On the other hand, the fragment-based strategy (also known as 
segmented read based strategy) does not require a genome annotation, but detects 
circRNAs based on mapping information of a split read’s alignment to the reference 
genome (split read refers to a sequencing read aligning to two distinct portions of the 
genome). When segments of a split read align to the reference in non-colinear order, they 
are marked as potential circRNA candidates by the tools. A discussion of the different 
tools is presented below and briefly summarized in Table 1.2. 
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Tool Strategy Aligner Filtering rules Number of 
circRNAs 
detected 
Blind spots/ 
drawbacks 
Find_ 
circ 
Segmented 
read based 
Bowtie2 
[37] 
GT-AG splice signals; 
100 kb distance; 
Unique anchor 
alignment; 
Anchor extension 
aligns completely;   
Break point resides 
within 2 nucleotides 
inside the anchor; 
Unambiguous 
breakpoint 
1,950 
(human); 
1,903 
(mouse); 724 
(nematode) 
Non-canonical 
splice signals not 
considered 
CIRI Splicing 
signal 
based 
BWA-
MEM 
[38] 
GT-AG splice signals; 
Filter out circRNAs in 
homologous genes or 
repeat regions 
3001 
(human) 
Non-canonical 
splice signal 
detection 
requires gene 
annotation file 
Map- 
splice 
Segmented 
read based 
Bowtie 
[39] 
Mismatch rate; base 
call quality and 
junction score 
7771 
(human); 646 
(mouse) 
Computational 
time, requires 
gene annotation 
KNIFE Pseudo-
reference 
based 
Bowtie, 
Bowtie2 
Reads aligning to 
linear junctions 
removed; 
User-specified 
junction overlap; 
Mate maps within the 
circle; 
Unique alignment with 
<= 2 mismatches for 
de novo detection; 
UCSC KnownGene 
annotated exons within 
1 Mb 
11,965 
(human) 
CircRNAs 
between exons > 
100 kb apart not 
considered 
DCC Segmented 
read based 
STAR 
[40] 
R2 maps within circle; 
Repetitive or 
homologous genes 
GT-AG 
2,382 
(human) 
Non-canonical 
splice signals not 
considered; 
requires gene 
annotation 
CIRC-
explorer 
Segmented 
read based 
STAR/ 
Tophat 
[40, 41] 
presence of XF tags; 
only reads that align 
on same chromosome 
included; 
Uniquely aligned 
reads 
2,119 
[poly(A)-];                      
9639 
[poly(A)-
/RNase R+] 
(human) 
Non-canonical 
splice signals 
and circRNAs 
from multiple 
genes not 
considered 
Computational 
time for Tophat 
Table 1.2: Summary of circRNA detection tools 
  13 
7.2.1 Find_circ 
Find_circ [3] is one of the first few circRNA detection algorithms developed and 
that uses the Bowtie2 [37] aligner. The algorithm first aligns RNAseq reads to the 
reference genome and extracts unmapped reads from this alignment. Next, 20-mer 
anchors are extracted from both ends of the unmapped reads and re-aligned to the 
reference genome to identify where they align in spliced exons. Anchors aligning in the 
reverse orientation are marked as potential circRNAs. The anchor alignments are further 
extended so that the complete read aligns and GU-AG splice sites flank the break point. 
Quality cut-offs as follows are then applied on the resulting list of potential candidates (1) 
unambiguous breakpoint detection; (2) a maximum of only two mismatches in the 
extension procedure; (3) the breakpoint cannot reside more than 2 nucleotides inside an 
anchor; (4) at least two independent reads support the junction; (5) unique anchor 
alignments; difference between best and next-best alignment scores of both anchors 
above 35 points; and (6) a genomic distance between the two splice sites of no more than 
100 kb. Candidates satisfying these filtering criteria are then collated to produce the final 
catalog of circRNAs. 
7.2.2 Mapsplice 
Mapsplice [36] is an aligner that can identify multiple types of splice junction 
events.  It is a de novo splice mapping tool that can segment reads into multiple anchors 
to detect canonical and non-canonical (GT-AG and non-GT-AG) splice junctions in 
RNAseq data. Mapsplice is implemented in two phases to identify such alignments. In 
the first phase or the ‘tag alignment’ phase, candidate alignments of the mRNA tags to 
the reference genome are determined. Tags with a contiguous alignment fall within an 
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exon and can be mapped directly to the reference genome, but those that span splice 
junctions require a gapped alignment. In the second phase known as the ‘splice inference 
phase’, splice junctions in the tag alignments are analyzed to determine a splice 
significance score based on the alignments and to generate the most likely spliced 
alignment for each tag. For circRNAs, reads from the fusion category are filtered for 
splice junctions on the same strand and within 2Mb, but in non-linear order.  
7.2.3 CIRCexplorer 
CIRCexplorer [42] uses a two-step mapping strategy for circRNA detection. In 
the first step, sequence reads from each sample are mapped to the reference genome 
using TopHat2 [41]. Unmapped reads from this step are extracted and mapped to the 
reference genome using TopHat-Fusion [43].  Reads that split and aligned on the same 
chromosome but in non-colinear ordering, indicated with special XF tags in output BAM 
files, are extracted as candidate back-spliced junction reads. These candidate reads are 
then realigned against existing gene annotations to determine the precise positions of 
donor or acceptor splice sites. Junction reads with shifted alignments against canonical 
splice sites are adjusted to the correct positions with custom scripts. Further, reads with 
alignments on different genes or non-canonical splice sites were largely from trans-
splicing or PCR errors, and were therefore discarded. 
7.2.4 DCC 
DCC (detect circRNAs from chimeric reads) [44] utilizes the output from the 
splice aware mapper STAR [40] to detect circRNAs. DCC first aligns RNAseq reads 
against the reference genome. The chimeric reads output by STAR are then filtered based 
on the following criteria to identify potential circRNA candidates: 1) if paired-end reads 
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are available, mapping of mates must be within the inferred circRNA; 2) when biological 
replicates are available, filtering by a minimal number of replicates is performed; 3) the 
presence of a canonical GT-AG splicing signal at the circRNA junction; 4) mitochondrial 
circRNAs are discarded; 5) candidates from repetitive or homologous regions are also 
discarded. DCC also estimates host gene expression from mapping data and reports 
circular to host gene expression ratios.  
7.2.5 KNIFE 
KNIFE [45] uses a statistical framework to calculate the posterior probability for 
every back-spliced read collected to predict whether it is a true positive circRNA. The 
algorithm first aligns RNAseq reads to the genome, rRNA sequences, and transcriptome 
references (hg19) as well as to custom linear and scrambled junction sequences using 
bowtie2. Possible back-splice junction reads that also map with high scores to the other 
references are discarded. The remaining reads are further classified into circRNA or 
decoy reads based on the mapping information of the mate when paired-end data are 
available. A read is considered circular if the mate aligns within the genomic region of 
the presumed circle defined by the junctional exons, or decoy if the mate aligns outside 
this region. Further, the reads in the linear and decoy categories are used to fit a 
generalized linear model (GLM). The GLM predicts the probability that each circular 
read is a class 1 (true positive) event versus a class 2 (false positive) event. 
7.2.6 CIRI 
Unlike the above described circRNA detection algorithms, Circular RNA 
Identifier (CIRI) [46] identifies circRNAs based on the mapping information of the reads, 
specifically from CIGAR (concise idiosyncratic gapped alignment report) signatures. The 
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CIGAR string in an alignment file is a sequence of base lengths and associated operation 
of those bases in alignment, such as match (M), insertion (I), deletion (D) etc. For e.g., 
30S115M indicates that in the sequence alignment procedure, 30 bases are soft-clipped 
and 115 bases match. CIRI takes as input sequence alignment (SAM) files generated with 
BWA-MEM [38] and scans for segments of a read that align to the reference genome in a 
chiastic (non-linear) order. To reduce the false positive rate, paired-end mapping and GT-
AG splicing signals are used as filtering criteria. The tool then scans the SAM file a 
second time to identify unbalanced junction reads that were not detected in the first scan, 
and performs additional filtering to remove candidates resulting from incorrectly mapped 
reads from homologous genes or repetitive sequences. In addition to exonic circRNAs, 
CIRI is able to identify circRNAs from intronic and intergenic regions when run on 
RNAseq datasets from the ENCODE project [21]. 
Although these circRNA detection algorithms are widely used, one main caveat 
with bioinformatics based circRNA identification is the highly divergent results produced 
by the different tools [47, 48]. The use of different aligners, heuristics and filtering 
criteria introduces variability in the circRNA catalogs produced by the different tools. 
Further, systematic ‘blind spots’ (false negatives) are also introduced by each tool due to 
the set of filtering criteria applied [49]. For example, most tools rely on the presence of 
canonical GT-AG splice signals and thus do not capture candidates with non-canonical 
splice signals. Most tools use a read count filter, which may not be ideal for circRNAs 
with low expression relative to their linear host. Given the low reliability on read counts, 
statistical approaches improve detection and classification of splice junctions, including 
novel ones. Nonetheless, sequencing errors and technical artifacts introduced during 
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RNAseq may still lead to false positive circRNAs, and hence statistical tests to estimate 
false discovery rates in circRNA detection need to be developed. 
 
8. CircRNA databases 
Several circRNA databases that have been curated using bioinformatics 
algorithms are briefly described below.  
CircBase [50] is one of the first publicly accessible circRNA databases and 
enables users to download merged and unified datasets of circRNAs reported from other 
laboratories. The database is freely accessible through a web server user interface 
implemented in HTML, CSS and JavaScript and utilizing a MySQL database. Users can 
query circBase using i) a simple search using identifiers, genomic co-ordinates, sequence 
etc; ii) a list search that allows the intersection of multiple search terms; iii) a table search 
that allows for conditional data retrieval. Data from published circRNA studies are added 
to circBase upon user request and the latest update was performed in July 2017.  
Circ2Traits [51] is a knowledgebase of potential associations of circRNAs with 
human diseases. Using data from Memczack et al. [23], circRNAs associated with 
disease-related miRNAs were identified, following which the likelihood of circRNA 
association with a disease is calculated. A network of predicted interactions is 
constructed between miRNAs, long non-coding RNAs, and circRNAs. The web interface 
and database were designed using PHP and MySQL, and the interaction networks were 
built using custom Java programs.  
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CircNet [52] is a database of tissue-specific circRNA expression profiles and 
circRNA-miRNA gene regulatory networks. CircNet is based on published circRNA 
studies as well as 464 RNAseq samples collected from independent studies across 26 
human tissues and 104 disease conditions.  CircRNAs were identified in these datasets 
using the algorithm from Memczack et al. [23]. Further, miRNA binding sites were 
identified by searching for miRNA target sequences in the circRNA isoforms.  Through 
their web interface, users can search for a gene or miRNA of interest to find its associated 
gene-miRNA-circRNA regulatory network. CircNet also provides genomic annotation of 
circRNAs with a genome browser integrated into their web interface and was last updated 
in August 2016. CircRNABase [53] is a similar database that predicts potential circRNA-
miRNA interactions, but is based 108 CLIP-seq datasets generated by 37 independent 
studies. It is thus able to overlap the predicted miRNA target interactions with high 
throughput CLIP-seq data.  
Cancer specific circRNA database (CSCD) [54] is a compilation of the circRNA 
detection results from 228 total RNA or polyA(-) RNAseq samples from both cancer and 
normal cell lines. Using CIRI, find_circ, CIRCexplorer and circRNA_finder, a total of 
272,152 cancer specific circRNAs were identified, 950,962 were identified in normal 
samples only and 170,909 were identified in both tumor and normal samples. Further, the 
microRNA response element sites and RNA binding protein sites for each circRNA were 
also predicted in silico. Similarly, tissue specific circRNA database (TSCD) compiles 
circRNA detection results from ENCODE/GEO datasets of 16 adult human tissues (60 
samples), 15 fetal human tissues (29 samples) and 9 mouse tissues (24 samples) [55]. 
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A total of 140,681 human adult, 164,069 human fetal and 15,980 mouse tissue specific 
circRNAs were identified using CIRI, find_circ and circRNA_finder. Open source web 
framework based on PHP and JavaScript, as well as MySQL tables were used to 
construct the CSCD and TSCD databases. Users can search for circRNAs by selecting 
sample type, sample name, gene symbol or the circRNA coordinates. 
CircRNAdb [56] is a database of 32,914 human exonic circRNAs selected from 
diverse sources. For each circRNA, this database provides details such as genomic 
information, exon splicing, genome sequence, internal ribosome entry site (IRES), open 
reading frame (ORF) and references. Users can search the web interface of this database 
using search terms such as chromosome name, gene symbol, transcript, and other 
keywords.  
CircInteractome [57] is a web tool for mapping RBP and miRNA binding sites on 
human circRNAs. In addition, circInteractome also enables users to (i) design junction-
spanning primers to detect circRNAs of interest, (ii) design small interfering RNAs 
(siRNAs) for circRNA silencing, and (iii) identify potential internal ribosome entry site 
(IRES). Further, it offers the ability to visualize the corresponding mRNA as well as the 
genomic and mature sequences of the circRNA.  
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9. Summary 
In summary, circRNAs are a class of RNAs that are gaining more attention in 
transcriptome research as representing a potential new factor that may influence 
transcriptional regulation. They are endogenous, non-coding, and abundantly and 
pervasively expressed in eukaryotes, especially in the mammalian brain. This thesis aims 
to advance current knowledge of circRNA expression in a tissue and region specific 
context with emphasis on the human brain, as well as address computational challenges. 
The overarching goal of our research unfolds over three aims: (i) evaluating circRNAs 
and their predicted impact on regulatory networks in cell specific RNAseq data (ii) 
developing assembly based workflows for de novo detection of full length circRNAs as 
well as in silico validation of selected circRNA junctions (iii) applying the assembly 
based detection and validation workflows, as well as existing detection algorithms to 
systematically identify and characterize circRNAs in functionally distinct human brain 
regions. 
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In chapter 2, we investigate circRNAs and their potential impact on regulatory 
networks using RNAseq data derived from posterior cingulate (PC) astrocytes in elderly 
individuals. To this end, we run existing circRNA detection algorithms and implement an 
in silico workflow to predict circRNA-miRNA-mRNA interaction networks in these 
samples. In chapter 3, we present novel assembly based workflows for de novo detection 
of full length circRNAs as well as in silico validation of selected circRNA junctions. 
These bioinformatics workflows are applicable to any non-polyA selected RNAseq 
dataset and can be used to characterize circRNAs across various sample types and 
diseases. In chapter 4, we apply these assembly based workflows and integrate results 
from existing algorithms to identify circRNAs and their regulatory networks in five 
functionally distinct cortical regions of healthy aged human brain. The brain regions we 
studied include cerebellum, inferior parietal lobe, middle temporal gyrus, occipital cortex 
and superior frontal gyrus. Using these analyses, we establish a reference dataset of 
circRNA expression profiles and regulatory networks in healthy elderly individuals in a 
region-specific manner. This resource along with existing databases such as circBase will 
be invaluable in advancing circRNA research as well as understanding their role in 
transcriptional regulation and various neurological conditions. Lastly, chapter 5 
summarizes the findings, conclusions, limitations as well as future directions of this 
research.
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CHAPTER 2 
CIRCULAR RNA EXPRESSION AND REGULATORY NETWORK PREDICTION IN 
POSTERIOR CINGULATE ASTROCYTES IN ELDERLY SUBJECTS  
(The contents of this chapter has been accepted for publication as a research article in 
the peer reviewed journal, BMC Genomics and is also on the bioRxiv preprint server:  
Sekar, S., Cuyugan, L., Adkins, J., Geiger, P., & Liang, W. (2018). Circular RNA 
expression and regulatory network prediction in posterior cingulate astrocytes in elderly 
subjects. bioRxiv, 268888) 
 
Abstract 
Circular RNAs (circRNAs) are a novel class of endogenous, non-coding RNAs that form 
covalently closed continuous loops and are abundant in the mammalian brain. A role for 
circRNAs in sponging microRNAs (miRNAs) has been proposed, but the circRNA-
miRNA-mRNA interaction networks in human brain cells have not been defined. 
Therefore, we identified circRNAs in RNA sequencing data previously generated from 
astrocytes microdissected from the posterior cingulate (PC) of Alzheimer’s disease (AD) 
patients (N=10) and healthy elderly controls (N=10) using four circRNA prediction 
algorithms. Overall, we identified a union of 4,438 unique circRNAs across all samples, 
of which 70.3% were derived from exonic regions. Notably, the widely reported CDR1as 
circRNA was detected in all samples across both groups by find_circ. Given the putative 
miRNA regulatory function of circRNAs, we identified potential miRNA targets of 
circRNAs, and further, delineated circRNA-miRNA-mRNA networks using in silico 
methods. Pathway analysis of the genes regulated by these miRNAs identified 
significantly enriched immune response pathways, which is consistent with the known 
function of astrocytes as immune sensors in the brain.  
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We thus performed circRNA detection on cell-specific transcriptomic data and identified 
potential circRNA-miRNA-mRNA regulatory networks in PC astrocytes. Given the 
known function of astrocytes in cerebral innate immunity and our identification of 
significantly enriched immune response pathways, the circRNAs we identified may be 
associated with such key functions. While we did not detect recurrent differentially 
expressed circRNAs in the context of healthy controls or Alzheimer’s, we report for the 
first time circRNAs and their potential regulatory impact in a cell-specific and region-
specific manner in aged subjects.  These predicted regulatory network and pathway 
analyses may help provide new insights into transcriptional regulation in the brain. 
1. Background 
CircRNAs are a class of endogenous, non-coding RNAs that form covalently 
closed continuous loops and are pervasively expressed in eukaryotes [1-3]. Though RNA 
circularization events were reported in the 1970s and 1990s [4-6], they were disregarded 
as molecular artifacts arising from aberrant splicing. However, with the advent of next-
generation sequencing technology, coupled with the development of computational 
algorithms to specifically detect these back-splicing events, numerous circRNAs have 
been reported since 2012. CircRNAs exhibit cell type-, tissue- and developmental stage-
specific expression [3, 7], and show evolutionary conservation between mouse and 
human [2, 3]. Furthermore, circRNAs are highly abundant in the mammalian brain 
compared to other tissues such as lungs, heart, kidney, testis and spleen in humans as well 
as in mouse neuronal cell lines [20], and are derived preferentially from neural genes 
[22].  
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 The abundance and evolutionary conservation of circRNAs suggests that they 
could play important roles in cellular processes. A few possible functions have been 
reported, including microRNA (miRNA) sponges [3, 6, 15, 16], mediation of protein-
protein interactions [19] and regulation of parental gene transcription [12]. Furthermore, 
a few circRNAs have been found to originate from disease-associated genomic loci, 
suggesting that circRNAs may regulate pathological processes [32, 34, 35, 58, 59]. Given 
these data, it is likely that circRNAs regulate RNA and protein networks, especially in the 
brain, but the regulatory pathways are still unknown. 
 In the present study, we characterized the expression and abundance of circRNAs 
in next generation RNAseq data of human brain astrocytes. Astrocytes, the most 
abundant glial cells, play several essential roles in the central nervous system, including 
homeostasis [60], immunity [61] and energy storage and metabolism [62, 63]. We 
previously evaluated these astrocytes, which were derived from the posterior cingulate 
(PC) of Alzheimer’s disease (AD) and healthy elderly control brains (age > 65), and 
identified AD-associated gene expression changes [64]. For this study, we used four 
circRNA prediction algorithms to identify circRNAs in these AD and control samples. 
Given the potential miRNA regulatory function of circRNAs, we then performed in silico 
identification of miRNA binding sites on the detected circRNAs, and further delineated 
putative circRNA-miRNA-mRNA networks in astrocytes. We describe here the first 
astrocyte-specific characterization of circRNAs and their interaction networks in elderly 
individuals. 
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2. Hypothesis 
We hypothesize that circRNAs are differentially expressed in posterior cingulate 
astrocytes across the AD and ND groups. Given the miRNA regulatory function of 
circRNAs, we further hypothesize that they regulate miRNAs that in turn regulate 
mRNAs that are significantly over/under-expressed in astrocytes.  
3. Results 
3.1 CircRNA detection in PC astrocytes 
The RNAseq data generated from our previous study was used for analysis [64]. 
This data set was generated from 20 human PC astrocyte pools: 10 from late-onset AD 
(LOAD) brains and 10 from no disease (ND) healthy elderly control brains. Over 
85,000,000 reads were sequenced for each sample, with an average mapping percentage 
of 70.8. On the FASTQ files generated from sequencing, we ran four circRNA prediction 
algorithms - CIRCexplorer [42], CIRI [46], find_circ [3], and KNIFE [45], and detected a 
total of 4,438 unique circRNAs with at least two supporting junction reads (publication - 
Additional file 1: Table S1). Among the detected circRNA candidates, a total of 2,331 
circRNAs were identified in the AD samples and 2,425 in the ND samples by at least one 
of the algorithms (Figure 2.1a). While 80% of the detected circRNAs had less than ten 
supporting reads (Figure 2.1b), 43 circRNAs had over 20 junction reads and were 
detected in more than one sample, and 31 circRNA candidates were detected in at least 
five samples with five or more supporting reads. Notably, the widely reported CDR1as 
circRNA was detected with a median read count of 52, by find_circ in all 20 samples and 
by CIRI in one of the samples. CircRNA 2:40655612-40657444 (chromosome:start-end) 
was detected in 12 of the 20 samples by two, three or all four algorithms in each sample 
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(publication - Additional file 1: Table S1). Furthermore, 548 circRNAs detected in our 
dataset were also reported in the four studies deposited in circBase [50] (publication -
Additional file 1: Table S1); various cell lines and tissue types were evaluated in these 
studies, including cerebellum, diencephalon, SH-SY5Y cells, Hs68 cells , HeLa cells and 
HEK293 cells.  
 Among all identified circRNAs, 416 were on chromosome 1 (length = 
249,250,621 base pairs), while only eight were detected on chromosome Y (length = 
59,373,566 base pairs), consistent with previous findings that the number of circRNAs 
detected is proportional to the length of the chromosome [26]. Based on RefSeq 
annotations, we observed that 70.3% of our candidates were derived from exonic regions 
(3,123/4,438), of which 94% (2,936/3,123) were in coding DNA sequences (CDS; 
excludes untranslated regions) (publication - Additional file 1: Table S1). Among the 
exonic circRNAs, 56.4% spanned one to 15 exons per circRNA, of which 20% were 
derived from single exons, while a small percentage of the exonic circRNAs (6.8%) 
spanned over 100 exons per circRNA.  
 As previously reported [47], we observed that the overlap among the circRNAs 
detected by the different tools was low. Overall, 243 circRNAs were predicted by all four 
tools, while each tool also predicted unique circRNAs (KNIFE—1680, find_circ—1077, 
CIRI—488, CIRCexplorer—198; Figure 2.1c). Most of the candidates called by all the 
tools originated from CDS (242/243; 99.5%) as well as intronic regions (232/243; 
95.5%), and 75% of the exonic candidates spanned two to six exons per circRNA.  
Further, the size distribution of all detected circRNAs, and the tool-wise and condition-
wise distribution of the circRNAs, are summarized in Figures 2.1d, e and f.  
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a.     b.  
c.  d.  
e.  f.  
Figure 2.1: Summary of circRNA prediction results. (a) Number of unique and 
common circRNAs in AD and ND PC. (b) Read count distribution of all detected 
circRNAs. (c) Intersection of circRNAs called by the four tools; the red bar indicates the 
number of circRNAs called by all four tools (d) Size distribution of all detected 
circRNAs. (e) Violin plots indicating the number of circRNAs predicted by each tool 
across PC samples along with the probability density. (f) Number of circRNAs predicted 
by each tool across PC samples, condition-wise. AD, Alzheimer’s disease; ND, no 
disease; circRNA, circular RNA; PC, posterior cingulate; bp, base pairs. 
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We next compared the relative abundance of circRNAs and corresponding linear 
RNAs using back-spliced reads and linearly spliced reads with the same splice sites 
(Methods; Table S2; Figure S1). We observed that for 26 circRNAs, the circular-to-linear 
ratio was 10 or greater and the linear count was not 0, such as circRNA 17:48823196-
48824063 from LUC7L3 (LUC7 like 3 pre-mRNA splicing factor; average back-spliced 
reads: 413, average linear reads: 16.32) and 1:67356836-67371058 from WDR78 (WD 
repeat domain 78; average back-spliced reads: 116.50, average linear reads: 9.50). 
Further, 44.6% (1,983/4,438) had no expression of linear RNA and 45.5% (2,018/4,438) 
had higher expression of the linear RNA.  
3.2 miRNA target prediction and delineation of circRNA-miRNA-mRNA regulatory 
networks 
Given the potential miRNA regulatory function of circRNAs, we next used the 
miRNA target prediction algorithms miRanda [65] and RNAHybrid [66] to predict the 
miRNA targets of the circRNAs detected in ten or more samples by at least one of the 
circRNA prediction algorithms (N = 10 circRNA candidates). Using a list of 2,588 
published miRNAs from miRBase [67], we detected 14,296 unique interactions between 
circRNAs and miRNAs that were predicted by both the miRNA target prediction 
algorithms and having a miRanda match score >=150. These interactions represent 
binding sites for miRNAs on each circRNA candidate, predicted based on 
complementarity in the miRNA seed region (nucleotide positions 2-7 in the miRNA 5’-
end). 2,398 miRNAs in the reference set were predicted to have binding sites on our input 
list of circRNAs. Among these, a set of 612 circRNA-miRNA interaction pairs were 
predicted to contain over 100 putative interaction sites by the miRanda algorithm 
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(publication - Additional file 3: Table S3). These 612 circRNA-miRNA interactions were 
predicted for six unique circRNAs and 448 unique miRNAs. Using Cytoscape [68], we 
visualized the circRNA-miRNA interaction network for these 612 interactions, wherein 
the edges between circRNAs and its target miRNAs are weighted by the number of 
predicted interaction sites for the circRNA-miRNA pair (Figure 2.2a). CDR1as was 
predicted to have binding sites for 74 distinct miRNAs and 63 binding sites for miR-7 
(Figure 2.2b). According to miRTarBase [69], miR-7 interacts with 578 target genes, 
some of which include SNCA (synuclein alpha), EIF4E (eukaryotic translation initiation 
factor 4E), KMT5A (lysine methyltransferase 5A), MAPKAP1 (mitogen-activated protein 
kinase associated protein 1), and MKNK1 (MAP kinase interacting serine/threonine 
kinase 1).  
We further employed the list of miRNA-mRNA target interactions common in 
both miRTarBase and TargetScan [70] databases, to determine the target genes of the 
above detected miRNAs. Overall, there were 2,530 target genes for our input list of 2,398 
miRNAs, of which 255 were also differentially expressed between the AD and ND 
groups based on DESeq2 analysis [71] of the linear RNAs (uncorrected p < 0.05, 
publication - Additional file 4: Table S4). Using this information about miRNA target 
mRNAs, we delineated a putative low-stringency circRNA-miRNA-mRNA network 
consisting of ten circRNAs, 53 miRNAs and 255 genes (publication - Additional file 9: 
Figure S2).  
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CircRNA 
microRNA 
target 
Number of 
binding sites 
predicted 
Target genes 
(differentially 
expressed) 
X:47431299-48327824 hsa-miR-139-5p 6 NOTCH1, STAMBP, 
TPD52 
8:144989320-145838888 hsa-miR-320a 2 
METTL7A, PBX3, 
PLS1, SEC14L1, 
VCL, VIM, VOPP1, 
YPEL2 
8:144989320-145838888 hsa-miR-320b 2 
RTKN, VCL, VOPP1 
X:47431299-48327824 hsa-miR-449a 1 
BAZ2A, MFSD8, 
NOTCH1, TSN, 
ZNF551 
8:144989320-145838888 
hsa-miR-125a-
3p 
1 
ANKRD62, 
C15orf40, 
COL18A1, MFSD11, 
MPEG1, MUL1, 
TTC31, WDR12, 
ZNF641 
X:47431299-48327824 
hsa-miR-125a-
5p 
1 
CD34, MEGF9, 
PANX1, RIT1, 
TP53INP1 
8:144989320-145838888 
hsa-miR-125a-
5p 
1 
CD34, MEGF9, 
PANX1, RIT1, 
TP53INP1 
X:47431299-48327824 hsa-miR-324-5p 1 FOXO1, MEMO1, 
PSMD4, SMARCD2 
14:23815526-24037279 hsa-miR-142-3p 1 
BTBD7, CLDN12, 
CPEB2, CSRP2, 
DAG1, KIF5B, 
PTPN23, WHAMM 
4:88394487-89061166 hsa-miR-133b 1 
FAM160B1 
4:88394487-89061166 hsa-miR-448 1 
DDIT4, PURG 
4:88394487-89061166 hsa-miR-339-5p 1 
AXL, HLA-E, 
METTL7A, ZNF285, 
ZNRF3 
Table 2.1: circRNA-miRNA-mRNA network elements for those circRNA-miRNA 
interactions predicted by both miRanda and RNAHybrid, with a miRanda match score >= 
180 and mRNA targets differentially expressed (uncorrected p < 0.05) with log2(fold 
change) > 2 or < -2 (high stringency network). 
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 Further, we used the same list of circRNAs detected in ten or more samples by at 
least one of the circRNA prediction algorithms, and increased the filtering stringency 
criteria to include a miRanda match score >= 180. We also restricted the candidate 
miRNAs to those with mRNA targets showing differential gene expression (uncorrected 
p < 0.05) with a log2(fold change) > 2 or < -2 between the AD and ND groups. Using this 
strategy, we established a high-stringency circRNA-miRNA-mRNA interaction network 
with four circRNAs, 11 miRNAs and 49 genes (Figure 2.3, Table 2.1). Our overall 
workflow is outlined in the publication - Additional file 10: Figure S3.  
3.3 Pathway analysis  
MetaCore pathway analysis on the 255 filtered differentially expressed target 
genes from the previous analysis revealed 112 perturbed pathways (corrected P < 0.01; 
Appendix Table 2.1, publication - Additional file 5: Table S5). 23 of these were immune 
response-related, such as IL-4 and IL-6 signaling pathways. This identification of 
impacted immune response pathways is consistent with the known function of astrocytes 
as immune sensors in the brain and aligns with our previous RNAseq study, which 
showed that immune system response pathways are impacted in AD PC astrocytes 
compared to ND PC astrocytes [64]. Additionally, signal transduction pathways that may 
be perturbed include post-translational modifications (PTMs) in BAFF-induced signaling, 
mTORC2 downstream signaling and protein kinase A (PKA) signaling.
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Figure 2.2: circRNA-miRNA network. (a) circRNA-miRNA interactions with 100 or more predicted binding sites. Red circular 
nodes: circRNAs, green triangular nodes: miRNAs.  
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b.  
Figure 2.2: circRNA-miRNA network. (b) miRNA network of CDR1as. The edge thickness in a and b is weighted by the number of 
binding sites predicted for the circRNA-miRNA interaction.  miRNA, micro RNA. 
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Figure 2.3: High stringency circRNA-miRNA-mRNA regulatory network. Network of circRNA-miRNA-mRNA regulation for those 
circRNA-miRNA interactions predicted by both RNAHybrid and miRanda, with miRanda match scores >= 180 and mRNA targets 
with differential expression (uncorrected p < 0.05) and log2(fold change) > 2 or < -2. Red circular nodes: circRNAs, green triangular 
nodes: miRNAs, blue square nodes: genes. mRNA, messenger RNA. 
Figure 3
circRNA miRNA gene
   35 
3.4 Lack of circRNA differential expression in AD PC astrocytes 
We analyzed our catalog of circRNA candidates to determine whether there were 
circRNAs uniquely expressed in either the AD or ND cohort. Though there were over 
2,000 circRNAs unique to each group, we did not observe them to be recurrent in the 
samples within their respective group. The log2 (fold change) for all candidates 
calculated using DESeq2 are summarized in the publication - Additional file 1: Table S1. 
93 circRNAs were unique to AD and called in at least two samples by at least one of the 
tools, and 82 circRNAs were unique to ND and called in at least two samples by at least 
one of the tools. These circRNA candidates were supported by at least two junction reads. 
To identify any differentially expressed candidates, we performed a Student’s t-test on 
those circRNAs commonly called across the two groups. Only two circRNAs trending 
towards significance (uncorrected p < 0.05) were identified and include 1:201452657-
201736927 (uncorrected p = 0.015) and 16:1583657-2204141  (uncorrected p = 0.046). 
 
4. Discussion and conclusions 
CircRNAs, which are abundant in the mammalian brain, represent a recent 
addition to the class of non-coding RNAs. In this study, we detected astrocytic circRNAs 
using whole transcriptome RNAseq data obtained from the PC of AD and ND subjects, 
and outlined circRNA-miRNA-mRNA regulatory networks. Based on the results from 
four different circRNA detection algorithms, we identified over 4000 unique circRNAs 
across all samples, the majority of which were derived from coding exons. Although we 
did not identify circRNAs that were differentially expressed and recurrent in AD or ND, 
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we were able to delineate circRNA-miRNA-mRNA networks for the ten most recurrent 
circRNAs expressed across both groups, and also incorporate our previous differential 
expression analysis data from the linear mRNA. We observe that the majority of 
identified circRNAs are unique in the AD or ND groups and are not recurrent across the 
respective groups. This could be due to their low abundance in those samples, which may 
be below detection levels, or could be due to biological differences between the two 
groups, which requires further investigation.  Pathway analysis on the differentially 
expressed miRNA target genes identified immune system related and signal transduction 
pathways. Notably, astrocytes are active players in cerebral innate immunity [72], and 
previous studies have reported that astrocytes respond to IL-4 signaling and potentially 
mediate between the immune effector cells and the nervous responders [73]. These 
predicted regulatory network and pathway analyses may help provide new insights into 
transcriptional regulation in the brain. 
The circRNA CDR1as (also known as CiRS-7, a circRNA sponge for miR-7) was 
detected in all 20 of our samples and is a widely reported circRNA with 63 conserved 
seed matches for miR-7, indicating possible miR-7 binding sites [3, 16]. Interestingly, 
overexpression of CDR1as in zebrafish decreased the midbrain size, suggesting a 
functional role for CDR1as in the brain, while a knock down of CDR1as down-regulated 
miR-7 targets in HEK293 cells [3]. This regulation is relevant since miR-7 plays a role in 
Parkinson’s disease, stress handling and brain development [3, 74], and also has tumor-
suppressive properties [74]. CDR1as also showed widespread expression in 
neuroblastoma and astrocytoma [75]. However, the expression of CDR1as was reduced 
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in AD hippocampal samples about 0.18-fold compared to controls [32], which we did not 
observe in our PC astrocyte dataset. Apart from CDR1as, the tools also predicted 
circRNAs derived from genes such as SLC8A1 (solute carrier family 8 - sodium/calcium 
exchanger - member 1), which is under-expressed in hippocampal neurons from aged 
human brains [76], SYT1 (synaptotagmin 1), whose increase was correlated to age-related 
spatial cognitive impairment in mice [77], PSAP (prosaposin), which is increased in 
activated glia during normal aging in mouse brains [78], and FGF17 (fibroblast growth 
factor 17).  
Although our dataset provides insights into the existence and abundance of 
astrocytic circRNAs in elderly individuals, there are a few limitations. Primarily, the 
whole-transcriptome data we analyzed was not generated from samples that were 
depleted of linear RNAs using RNase R (ribonuclease R), an exoribonuclease that 
selectively digests linear RNA but leaves behind lariat or circRNA structures. Due to the 
presence of a larger pool of transcripts, which are mostly linear RNAs, RNAseq may not 
have comprehensively captured all the circRNAs in the samples. Notably, this 
enrichment step has been used by various groups to enrich for circRNAs for sequencing 
analyses [2, 3, 24].  
Another limitation of bioinformatics-based circRNA detection is the highly 
divergent results produced by different algorithms. We observed this in our analyses and 
it has also been reported by two recent circRNA benchmark studies [47, 48]. The 
algorithms utilize different aligners, heuristics and filtering criteria, thus introducing 
‘blind spots’ (false negatives) when addressing biases introduced by each method [49]. 
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For example, find_circ and CIRI rely on filtering for GT-AG splice signals and thus may 
not capture candidates with non-canonical splice signals. Further, most tools use a read 
count filter, which may not be ideal for circRNAs with low expression relative to their 
linear host [36]. Given the low reliability on read counts, statistical approaches improve 
detection and classification of splice junctions, including novel ones [79]. Among the 
circRNA detection algorithms, KNIFE implements a logistic generalized linear model to 
distinguish true circRNAs, and is therefore able to identify circRNAs derived from non-
canonical splice sites. Notably, KNIFE achieves a more balanced performance, for 
precision and sensitivity, compared to other circRNA detection algorithms, as described 
in one of the benchmarking studies [48]. We observed in out dataset that KNIFE detected 
more circRNAs compared to find_circ, CIRI and CIRCexplorer. Nonetheless, sequencing 
errors and technical artifacts introduced during RNAseq can still lead to false positive 
circRNAs, and hence statistical tests to estimate false discovery rates in circRNA 
detection need to be developed.   
While circRNAs have continued to gain attention as an abundant non-coding 
RNA species with potential regulatory functions, our understanding of their expression in 
various cell and tissue types remains limited. To address this challenge, we describe an 
analysis of astrocytic circRNAs in RNAseq data from elderly individuals, and we 
delineate potential circRNA-miRNA-mRNA regulatory networks. Given the role of 
astrocytes in signaling and synaptic modulation, and as immune sensors in the brain, the 
circRNAs we identified may be associated with such key functions. Further 
characterization using circRNA-enriched datasets will help us understand the atlas of 
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circRNA expression in the context of specific cell types and conditions, including aging 
and AD. In addition, downstream functional studies are needed to clarify how and 
whether circRNAs act as hubs for influencing protein expression and cellular processes. 
As we continue to piece together the factors involved in transcriptional regulation, we 
will both better understand basic cellular mechanisms and set the stage for developing 
improved therapeutic strategies for AD and other diseases. 
 
5. Methods 
5.1 Sample acquisition, library preparation and paired-end sequencing 
Detailed methods for sample acquisition, immunohistochemistry using an 
aldehyde dehydrogenase 1 family, member L1 (ALDH1L1) antibody, microdissection, 
RNAseq library preparation and sequencing of astrocytes are described in our previous 
publication [64]. Briefly, postmortem human brain samples were collected at the Banner 
Sun Health Research Institute’s (BSHRI) Brain and Body Donation Program (BBDP) 
from 10 clinically classified LOAD subjects (4 males and 6 females; 5 APOEε3/4 
subjects and 5 APOEε3/3 subjects) and 10 ND controls (6 males and 4 females; 5 
APOEε3/4 subjects and 5 APOEε3/3 subjects). All subjects were enrolled in the BSHRI 
BBDP in Sun City, Arizona, and written informed consent for all aspects of the program, 
including tissue sharing, was obtained either from the subjects themselves prior to death 
or from their legally-appointed representative.  The protocol and consent for the BBDP 
was approved by the Western Institutional Review Board (Puyallap, Washington). 
Clinical and pathological donor demographics are summarized in the publication - 
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Additional file 6: Table S6. Approximately 300 astrocytes were laser capture 
microdissected from PC brain sections and total RNA was isolated from the cell lysates, 
followed by cDNA creation and library generation. Equimolar pools of libraries were 
sequenced by synthesis on the Illumina HiSeq2000 for paired 83 base pair reads. 
 
5.2 Data analysis 
The data analysis workflow is summarized in the publication - Additional file 10: 
Figure S3. Raw sequencing data, in the form of basecall files (BCLs), were converted to 
FASTQ format using Illumina’s bcl2fastq conversion software and quality checked using 
FastQC [80]. To eliminate variance in circRNA detection that could arise due to 
differences in the number of sequencing reads, all FASTQ files were down-sampled to 
85,547,262 reads using seqtk [81]. The down-sampled FASTQ files were then run 
through four different circRNA prediction algorithms—CIRCexplorer (v1.1.10), CIRI 
(v2), find_circ (v1), and KNIFE (v1.4), using the parameter settings described in the 
publication - Additional file 7: Table S7. CircRNAs from each sample with at least two 
supporting reads were used for further downstream processing and analyses. CIRI 
produces 1-based circRNA coordinates, and was therefore converted to 0-based 
coordinates to be consistent with the other three algorithms. We then annotated our 
catalog of circRNA candidates using the UCSC RefSeq annotations [82] and BEDtools 
[83].  
The ratio of circular to linear RNA isoforms was calculated using the approach 
described in [20]. For each circRNA candidate, we used the number of back-spliced reads 
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for circRNA quantification (Nc) and the number of linear reads supporting the same 5’ or 
3’ splice junction (Nl5 or Nl3) as the number of linear RNA reads. The linear junction 
supporting reads were obtained by aligning our RNAseq data to the reference genome 
(GRCh37) using STAR [40].  
Circular to linear ratio =  𝑁𝑐/max(𝑁𝑙5 , 𝑁𝑙3)  
5.2.1 miRNA target prediction 
For circRNAs detected in at least 50% of the samples, we next conducted miRNA 
binding site prediction using the miRanda [65] and RNAHybrid [66] algorithms. The 
miRanda algorithm finds potential target sites for miRNAs in a genomic sequence using a 
two-step strategy. First, a dynamic programming local alignment is implemented between 
the miRNA sequence and the sequence of interest (circRNA sequence in this study), 
scoring the alignment based on sequence complementarity (match score). In the second 
step, the thermodynamic stability of the resulting RNA duplex is estimated based on the 
high-scoring alignments from the first phase. The RNAHybrid algorithm finds the 
energetically most favorable hybridizations of a small RNA to a large RNA. Only those 
circRNA-miRNA interactions predicted by both the algorithms are used for our 
downstream network construction and analyses. From the list of commonly predicted 
circRNA-miRNA interactions, we filtered for those having a miRanda match score >= 
150.  
5.2.2 circRNA-miRNA-mRNA network construction 
miRNA-mRNA interactions that are common in both miRTarBase [69] and 
TargetScan [70] were then used to determine the gene targets of each filtered miRNA and 
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compared with genes identified using differential expression analysis of the linear RNAs 
(uncorrected p < 0.05; DESeq2 performed as described in our previous publication). 
Using these data, we outlined a low-stringency circRNA-miRNA-mRNA regulatory 
network with custom python scripts and visualized the network using cytoscape. We 
further filtered for the circRNA-miRNA interactions with miRanda match scores >= 180 
and miRNAs with mRNA targets showing differential expression (uncorrected p < 0.05, 
log2[fold change] > 2 or < -2) to outline a high-stringency circRNA-miRNA-mRNA 
network.  
5.2.3 Pathway analysis  
On the list of filtered miRNA target genes with DESeq2 uncorrected p < 0.05, we 
performed pathway analysis using MetaCore GeneGO (v6.32.69020) from Thompson 
Reuters to predict pathways that are commonly impacted in the AD and ND groups. The 
results were filtered for enriched pathways with a false discovery rate (FDR)-corrected P 
< 0.01. 
 
6. Ethics approval and consent to participate 
All subjects were enrolled in the BSHRI BBDP in Sun City, Arizona, and written 
informed consent for all aspects of the program, including tissue sharing, was obtained 
either from the subjects themselves prior to death or from their legally-appointed 
representative.  The protocol and consent for the BBDP was approved by the Western 
Institutional Review Board (Puyallap, Washington). 
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10. Summary 
In summary, we utilized astrocyte specific RNAseq data to identify astrocytic 
circRNAs in aged subjects (N=20). Utilizing four circRNA prediction algorithms, we 
identified a total of 4,438 unique circRNAs across samples, majority of which were 
derived from exonic regions. The widely reported CDR1as circRNA was detected in all 
20 samples with a median of 52 supporting reads. Although we did not identify circRNAs 
that were differentially expressed and recurrent in AD or ND, we performed in silico 
prediction of putative miRNA binding sites on circRNAs detected in at least half the 
samples, and delineated a low- and high-stringency circRNA-miRNA-mRNA regulatory 
network. Pathway analysis on the genes from our low-stringency network revealed 
significantly impacted immune response pathways, which aligns with the known function 
of astrocytes as immune sensors in the brain. While we did not detect circRNAs 
recurrently expressed in the context of healthy controls or Alzheimer’s, we are the first to 
report circRNAs and their potential regulatory impact in a cell-specific and region-
specific manner in aged subjects. Continued analyses such as these sets the foundation for 
circRNA characterization and understanding their expression and regulatory networks in 
specific cell types and regions in the brain. 
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CHAPTER 3 
NOVEL ASSEMBLY BASED APPROACHES FOR FULL LENGTH DETECTION 
AND IN SILICO VALIDATION OF CIRCULAR RNAS 
Abstract 
 CircRNAs are formed when exons ‘back-splice’ to each other in a non-linear 
fashion. Although several algorithms have been developed in order to detect these back-
splicing events, these methods are limited by a few caveats, which we try to address in 
this chapter. Firstly, the existing algorithms only look for the presence of the junction and 
hence we do not detect the full length of the circRNA. We developed DeFuCir (Detection 
of Full length CircRNA), an assembly based bioinformatics workflow for full length 
circRNA detection. DeFuCir leverages the presence of soft-clipping signals in the 
alignment between assembled contigs and the reference genome, and further looks for 
back-splicing in such contigs to detect potential full length circRNAs.  Secondly, existing 
algorithms produce divergent results, and hence there is a need for an in silico validation 
strategy to distinguish true positive circRNAs.  To this end we developed ACValidator 
(Assembly based CircRNA validator) that can be used as an in silico validation strategy 
as well as a candidate selection tool for experimental validation. ACValidator extracts 
reads from a fixed window on either side of the circRNA junction of interest and 
assembles them to generate contigs. These contigs are then checked for overlap with the 
circRNAs sequence to check for overlap across the junction. Both these assembly based 
methods achieve reasonable precision with a higher coverage of back-spliced reads and 
bring a new perspective to circRNA detection methods. 
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1. Background 
Circular RNAs (circRNAs) represent a large class of ubiquitously expressed non-
coding RNAs that are formed when exons ‘back-splice’ to each other in a non-linear 
fashion. With the advent of high throughput sequencing technologies and bioinformatics 
algorithms, thousands of circRNAs have been reported in multiple cell and tissue types 
by various studies. Notably, these studies have found that circRNAs are highly abundant, 
evolutionarily conserved and are more stable than linear RNAs since they are covalently 
closed loops without a 5’/3’ termini or a polyadenylated tail. Hence, there has been 
growing interest in the functional relevance of these RNAs. Nonetheless, recent studies 
have demonstrated that they can act as miRNA regulators, decoys to RNA binding 
proteins, and as well as regulators of parental gene transcription.  
Several computational tools have been developed to identify these back-splicing 
events in RNAseq data (Chapter 1, Table 1.2).  There are two broad strategies used by 
these tools to identify circRNAs: 1) a pseudo-reference based strategy used by KNIFE; 
and 2) a fragment-based strategy used by find_circ, CIRCexplorer, Mapsplice and DCC. 
While KNIFE constructs a pseudo-reference of all possible out of order exons to align 
reads against, fragment-based strategies detect circRNAs based on the mapping 
information of a split read’s alignment to the reference genome. When segments of a split 
read align to the reference in a non-colinear order, they are marked as potential circRNA 
candidates. Apart from these, CIRI uses CIGAR signatures in the alignment file to 
identify circRNAs. All of these strategies are alignment based and only look for the 
presence of the circRNA junction. However, identification of full length circRNAs is 
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important for understanding their functional relevance. Further, recent comparison 
studies [47, 48] have revealed that these algorithms produce divergent results, as has also 
been observed in our results in Chapter 2. Hence, there is a need for an in silico 
validation approach that can help distinguish true versus false positive circRNAs 
identified using these algorithms. 
Previous structural variant detection tools for DNA sequencing data, such as 
FACTERA [85], CREST [86] and ScanIndel [87], leverage the presence of soft-clipping 
signals in alignment files to detect indels or translocations. These tools are based on the 
fact that clipped boundaries of truncated reads (also known as ‘soft-clipped’ reads) may 
represent potential DNA breakpoints whereby the soft-clipped portion of a read matches 
the mapped portion of its mate.  Here, we apply a similar principle to utilize soft-clipping 
signals in order to detect circRNAs and additionally use assembled contigs to predict full 
length circRNA sequences.  
We present two novel computational methods in this study: for the first method, 
we present a de novo assembly based strategy to detect full length circRNA transcripts. 
This approach utilizes contigs assembled by trinity [88] and identifies soft-clipped bases 
in the assembled contigs. The advantage of our approach over existing alignment based 
strategies is the ability to detect essentially full length circRNAs. For the second method, 
we present a novel in silico approach to validate a given circRNA junction of interest. 
This approach also utilizes the trinity assembler, which assembles reads on either side of 
the circRNA junction of interest from an alignment file. Generation of a contig that 
crosses the junction is considered evidence for the presence of a circRNA. This approach 
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is especially useful in distinguishing true positive candidates as well as in selecting 
potential candidates for experimental validations. We present a systematic evaluation of 
our approaches using simulated circRNA datasets generated using CIRIsimulator [46] as 
well as real datasets consisting of ribonuclease R (RNase R) treated and non-treated 
sample pairs.  
 
2. Hypothesis 
We hypothesize that using an assembly approach can construct potential full length 
circRNA transcripts. Further, we also hypothesize that assembling reads near the 
circRNA junction can generate contigs that cross over the junction and can hence be used 
as an in silico validation strategy. 
 
3. Methods 
3.1 Assembly based detection of full length circRNAs 
We developed DeFuCir (Detection of Full length CircRNAs using assembly and 
soft-clipping), an assembly based bioinformatics workflow for circRNA detection (Figure 
3.1). The first step of our pipeline assembles transcripts using all RNAseq reads from our 
sample of interest using trinity. Once trinity assembles contigs that are representative of 
full length transcripts, a series of rules to filter for potential circRNA transcripts among 
all assembled transcripts is implemented. During this step, the output from trinity, which 
has the assembled contigs in the form of a fasta file, is first aligned to the reference 
genome (GRCh37) using BWA-MEM [38]. The resulting binary alignment mapping 
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(BAM) file is run through a custom python script that inspects each contig’s alignment 
record and collects its start and end coordinates. Further, a second script reads through 
each alignment record in the BAM file and extracts contigs that have a soft-clipping 
signal in its CIGAR string. For contigs having a soft-clipping signal, the script extracts 
the sequence of the lowest and the highest segments of the contig aligning to the 
reference, lowest and highest being the 5’ most and 3’ most segments of the contigs 
alignment to the reference.  The tool next checks if the lowest segment of the contig and 
the soft-clipped portion of the highest segment of the contig overlap with each other. If 
the lowest segment matches in its entirety to the soft-clipped portion, this is considered as 
evidence for a back-spliced transcript and thus annotates the contig as a circRNA. 
Further, the tool also checks if the reverse or the reverse complementary sequence of the 
lowest segment overlaps with the soft-clipped portion to further check for back-splicing 
events. Lastly, contigs passing our filtering criteria are collected and their start and stop 
positions are extracted to generate the predicted circRNA coordinates. When comparing 
the circRNA coordinates generated from DeFuCir with existing approaches, we allow a 
10 base pair (bp) wiggle room to allow for slightly shifted alignment boundaries. Lastly, 
using a separate parsing script and samtools, the tool also extracts reads aligning to the 
assembled circular transcript to count how many reads support the circular contig.  
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Figure 3.1: DeFuCir workflow. RNAseq reads are assembled using trinity and the 
resulting fasta file is aligned to the reference genome (GRCh37). Among these 
alignments, those that have soft-clipping signals at the end of a contig (contig alignments 
1 and 3; soft-clipping indicated by the colored bases at the 5’ and 3’ ends) are further 
investigated to determine if they map back to the beginning sequence of the same contig. 
R1, Read 1; R2, Read2 
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3.2 Assembly based in silico validation of circRNAs  
In order to perform an in silico validation of selected circRNA junction(s), we 
developed a bioinformatics workflow, ACValidator (Assembly based CircRNA 
Validator) that takes as input a SAM file and the circRNA coordinate(s) to be validated 
(Figure 3.2). ACValidator operates in three phases: extraction of reads from SAM file, 
generation of a “pseudo-reference” file, and assembly and alignment of extracted reads. 
First, reads are extracted from a user-defined window w on either side of the given SAM 
file [(start-coordinate + w); (end-coordinate - w)]. Our datasets were run using a window 
size of 300 bp but users can adjust this window according to the library insert size or read 
length. The tool thus extracts reads aligning between the proximal end of the start 
coordinate window to the distal end of the end coordinate window from the SAM file 
using samtools. The extracted reads are converted into fastqs for downstream processing. 
In the second phase, a “pseudo-reference” of the sequence around the circRNA junction 
of interest is generated. This is performed by also extracting w bps from the end and start 
of the circRNA junction from the genome reference fasta file (GRCh37) and 
concatenating the two sequences from end to end to capture the region on either side of 
the circular junction. Lastly, fastqs from phase 1 are assembled using the trinity 
assembler and the assembled contigs fasta file is aligned to the pseudo-reference from 
phase 2 using BWA-MEM. Each resulting alignment record is then examined to check 
whether they overlap with the junction sequence using four separate stringency criteria. A 
high stringency cut off requires an overlap of 30 bp on either side of the junction (total 
60bp overlap). A 20 bp overlap on either side of the circRNA junction (total 40bp 
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overlap) is defined as a medium stringency cut off, a 10 bp overlap on either side (total 
20 bp overlap) is defined as a low stringency cut off and a 5 bp overlap on either side 
(total 10 bp overlap) is defined as a very low stringency cut off.  
Figure 3.2: ACValidator workflow. ACValidator takes as input the alignment file and 
the circRNA junction(s) to be validated. Reads from either side of the junction within a 
user-defined window are extracted and assembled using trinity.  The assembled contigs 
are then checked for overlap with the sequence of the junction to be validated.  
 
 
3.3 Datasets used for evaluation 
3.3.1 Simulated dataset 
We used CIRI-simulator [46] to generate five synthetic RNAseq datasets that had 
varying coverages of circular and linear RNA (Table 3.1) to evaluate our workflows. 
CIRI-simulator takes as input a fasta formatted reference file and a GTF annotation file 
based on which it generates circular and linear RNA sequences. Additionally, users can 
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also specify parameters such as read length, minimum circRNA size, insert size, 
sequencing error rate, etc. Recently, Zeng et al. [48] re-designed this tool to generate 
synthetic reads for circRNAs deposited in circBase rather than randomly joining exons as 
per the original design of the tool. The simulated datasets we generated for this study had 
between two to 24 supporting reads and a minimum circRNA size of at least 50 bps. 
Overall, there was an average of 56,319 circRNAs across these five simulated datasets. 
Further CIRI-simulator ensures these circRNAs map to locations distributed across the 
entire genome, thereby eliminating any bias that may be associated with genomic 
location (Figure 3.3). 
    
5
4
 
 
 
Simulation 
set 
# of reads 
CircRNA 
coverage 
Linear RNA 
coverage 
Cell 
line/tissue 
type used 
from circBase 
Read 
length 
(bp) 
Min size of 
circle (bp) 
Insert 
size (bp) 
# True 
circles 
1  2,142,226  10 0 HeLa only 101 50 350 14,689 
2  28,920,516  10 0 All* 101 50 300 89,293 
3  19,648,436  5 5 All 82 200 300 82,010 
4  7,809,356  2 8 All 82 200 300 82,010 
5  1,801,264  1 10 HeLa only 82 200 300 13,591 
Table 3.1: Simulation dataset parameters 
All* cell line/tissue type includes data generated from human cerebellum, diencephalon, SH-SY5Y cells, Hs68 cells, HeLa cells and 
HEK293 cells
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Figure 3.3: Chromosomal distribution of simulated datasets 
 
3.3.2 Non-simulated datasets 
We included six pairs of RNase R treated and non-treated samples (N = 12). 
Three of these were downloaded from the sequence read archive (SRA) [89] and were 
generated from HeLa and Hs68 cell lines that were treated or not treated with RNase R. 
The remaining three samples were generated in-house in the Liang lab, TGen, from total 
RNA extracted from the middle temporal gyrus (MG) of human brain (Chapter 4, 
Methods). Sample information is summarized in Table 3.2.  
 
   56 
Data 
source 
Sample ID 
Cell line/ 
tissue 
type 
RNase 
R 
treated
? 
Total # 
reads 
# mapped reads 
SRA SRR1636985 HeLa Yes 26,619,490 24,370,337 
 
SRR1637089 HeLa No  89,866,900 63,842,205 
 
SRR1636986 HeLa Yes 47,011,426 42,027,801 
 
SRR1637090 HeLa No  71,370,620 53,957,685 
 
SRR444974 Hs68 Yes 316,611,710 271,345,091 
 
SRR444655 Hs68 No 314,106,316 109,706,923 
In-house MG_1 MG Yes 107,609,934 96,300,242 
 
MG_5 MG No 96,215,516 86,315,844 
 
MG_2 MG Yes 96,840,790 86,560,619 
 
MG_6 MG No 101,609,754 90,750,108 
 
MG_3 MG Yes 111,576,344 100,264,691 
 
MG_7 MG No 111,314,114 98,894,498 
Table 3.2: Summary of real, non-simulated datasets used in this study 
 
3.4 Software requirements/dependencies 
Both workflows were implemented on a Linux-based high performance computing 
cluster and have minimal requirements and dependencies. These include: (a) Trinity 
v2.3.1 or above; (b) Python v2.7.13 or higher with pysam package installed; and (c) 
Bowtie2 v2.3.0, Samtools v1.4, BWA v0.7.12. 
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4. Results and Discussion 
4.1 Assembly based detection of full length circRNAs 
We developed DeFuCir, a rule-based bioinformatics workflow for the de novo 
detection of full length circRNAs from trinity assembled contigs. Unlike existing 
alignment based methods that look for the presence of a back-spliced junction (Chapter 
1), this workflow detects full length circRNAs from assembled transcripts based on the 
presence of soft-clipping signals (Methods). We evaluated our workflow on both 
simulated and non-simulated datasets. 
We first evaluated the performance of our soft-clipping workflow using simulated 
datasets (Table 3.1). We were able to detect 1,089 to 15,909 candidate circRNAs across 
the different simulated datasets. Comparing with the true positives in each set as output 
by CIRI-simulator, our approach achieves reasonable precision because although fewer 
candidates are detected, the majority of these are true positives (Table 3.3). The main 
advantage of our workflow over existing methods is that we detect full length circular 
transcripts, while existing approaches only capture reads at circRNA junctions. This may 
be especially useful in detecting alternative splicing isoforms whereby certain exons may 
not be present in the circRNA as inferred (Figure 3.4b). 
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Sample 
# True 
circles 
Total number 
of contigs from 
trinity 
# contigs with 
back-spliced 
soft-clipping 
signals 
(circRNAs) 
# common 
circRNAs 
allowing 10 
bp wiggle 
room 
P % 
Simulated1 14,689 16,307 2,676 1,827 68 
Simulated2 89,293 117,807 15,909 8,706 55 
Simulated3 82,010 115,112 10,616 5,638 53 
Simulated4 82,010 88,594 6,056 3,285 54 
Simulated5 13,591 22,689 1,089 687 63 
Table 3.3: Summary of DeFuCir results on simulated datasets. P: Precision, 
calculated as: TP/TP + FP, where TP: True positives, FP: False positives 
 
 
We next ran DeFuCir on SRA and in-house generated datasets consisting of 
RNase R treated and non-treated sample pairs (Methods). When evaluated on the SRA 
samples, DeFuCir detected 2,476 to 15,076 circRNA contigs. Comparing these results 
with circRNA candidates identified using existing tools, find_circ, CIRI, Mapsplice, 
KNIFE, DCC and CIRCexplorer, we detected a total of 4,810 circRNAs across all 
samples that were common between the two approaches, with an average of 9% overlap 
per sample (Table 3.4). We observed similar results when implementing our soft-clipping 
approach for in-house generated MG samples. Overall, DeFuCir detected 11,567 to 
24,388 circRNA candidates, among which 191, 154 and 220 candidates overlap between 
the treated and non-treated pairs. A total of 5,201 circRNAs across all samples overlap 
between DeFuCir and existing approaches. Among these overlapping candidates, we 
looked for candidates present in both the treated and non-treated pair to identify a high-
confidence list of circRNA candidates that are not depleted by RNase R (Table 3.4). As 
illustrated in Figure 3.4, candidates detected by DeFuCir span the full length of the 
circRNA (top panel), whereas existing tools only look for the presence of reads near the 
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predicted circRNA junction (bottom panel). Furthermore, Zeng et al. [48] curated a list of 
282 PCR (polymerase chain reaction) validated circRNAs from various published 
studies. Though these validated circRNAs are derived from different cell lines and tissue 
types, we compared our catalog of back-spliced contigs with the validated circRNAs and 
detected overlapping events (Table 3.4).
    
6
0
 
 
 
Sample 
RNase 
R 
treated? 
# contigs with 
back-spliced soft-
clipping signals 
(circRNAs) 
#  
overlap 
across pair 
# overlap with 
existing 
approaches 
Intersection 
between 
treated-non-
treated pairs 
in  columns 5 
# overlap with validated 
circRNAs (N=282) 
MG_1 Yes 17,599 191 1,987 106 20 
MG_5 No 11,567 
 
391 
 
13 
MG_2 Yes 19,504 154 1,319 77 17 
MG_6 No 17,205 
 
348 
 
18 
MG_3 Yes 44,518 220 850 78 18 
MG_7 No 24,388 
 
306 
 
15 
       
SRR1636985 Yes 2,476 40 423 35 17 
SRR1637089 No 12,622 
 
612 
 
8 
SRR1636986 Yes 4,086 57 254 43 24 
SRR1637090 No 7,467 
 
281 
 
19 
SRR444974 Yes 15,076 90 3,148 35 26 
SRR444655 No 7,494 
 
92 
 
7 
Table 3.4: Summary of results from running DeFuCir on non-simulated datasets 
‘# overlap’ indicates ‘number of candidates overlapping’; validated circRNAs from Zeng et al 2017
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a. 
 
 
Figure 3.4: Integrated genomics viewer (IGV) screen shots of two circRNA candidates detected by DeFuCir and existing tools (panel a 
shown) 
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b. 
 
Figure 3.4: Integrated genomics viewer (IGV) screen shots of two circRNA candidates detected by DeFuCir and existing tools (a. 
5:24,535,220-24,537,783; b. 10:105,953,623-105,967,582). The top panel in each screenshot is the BAM file from DeFuCir while the bottom 
panel is from running through CIRI and CIRCexplorer in these examples. Arrow marks indicate contigs/reads supporting the circRNA 
transcript/junction. We observe that DeFuCir generates contigs spanning the exons constituting the circRNA transcript and in (b) there are no 
contigs over exons 2 and 3 indicating that there may be alternative splicing, which cannot be inferred from the CIRCexplorer BAM file.  
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4.2 Assembly based in silico validation of circRNAs  
Given the disparity among circRNAs identified by existing circRNA algorithms, 
we implemented an assembly based workflow for in silico validation of circRNAs using 
ACValidator (Methods). Briefly, ACValidator takes as input the circRNA junction(s) to 
be validated and the alignment file. Using a user-defined window, reads from either side 
of the junction are extracted and assembled using trinity.  The assembled contigs are then 
checked for overlap with the sequence of the junction to be validated.  
 
To evaluate ACValidator, we first used the same five simulation datasets 
described above. We used the top 100 true candidates in terms of the highest number of 
read counts as true positives, and randomly selected non-circRNA coordinates as false 
positive candidates. As summarized in Table 3.5, our workflow achieves higher 
sensitivity and precision on datasets with a higher number of circRNA supporting reads 
and gradually reduces with circRNA coverage. In most cases, this is due to the fact that 
trinity does not identify sufficient reads to assemble across these regions and hence does 
not generate contigs. In summary, simulations 1 and 2 achieve 92 and 83% sensitivity 
respectively while the remaining 3 datasets achieve relatively lower sensitivity.  Further, 
we calculated the F1 score [F1 = (2 * Precision * Sensitivity)/ (Precision + Sensitivity)], 
which indicates how well a tool achieves sensitivity and precision simultaneously, and 
observed the results to be consistent with the sensitivity measurements, indicating that 
higher circRNA coverage yields better performance of our approach.  
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Simulation 
set 
# true 
candidates 
# false 
candidates 
TP FN FP P S Sp F1 
1 100 100 92 8 1 99 92 99 0.95 
2 100 100 83 17 2 98 83 98 0.89 
3 100 100 76 24 11 87 76 90 0.81 
4 100 100 71 29 1 99 71 99 0.82 
5 100 100 60 40 1 98 60 99 0.74 
Table 3.5: Results of ACValidator on the top 100 candidates and false candidates  
The top 100 candidates are those with the highest number of supporting reads and false 
candidates are randomly selected non-circRNA coordinates. In order to determine the FP 
rate, 100 false candidates were also tested to evaluate how many were validated by our 
tool. 
TP, True positives; FN, False negatives; FP, False positives; P, Precision; S, Sensitivity; 
Sp, Specificity.  
P =TP/(TP+FP); S = TP/(TP + FN); Sp = TN/(TN+FP); F1 = (2 * P * S)/ (P + S) 
 
 
We extended these calculations to the top 200 as well as bottom 200 candidates, 
as defined by the number of supporting reads and observed the same trend in sensitivity 
and precision measurements (Table 3.6). Furthermore, we also evaluated sensitivity using 
different thresholds for the number of overlapping bases (30 bp, 20 bp, 10 bp and 5 bp; 
Methods) to assess whether we achieve “saturation” in the sensitivity measurements. For 
majority of the cases, we observe that there is no drastic difference in the number of 
candidates validated across the different thresholds. 
 
 
 
 
 
   65 
a. Top 200 
candidates 
 
        Simulation 
set HS MS LS VLS 
S % 
(HS) 
S % 
(MS) 
S % 
(LS) 
S % 
(VLS) 
1 180 183 183 183 90.00 91.50 91.50 91.50 
2 158 163 164 164 79.00 81.50 82.00 82.00 
3 149 156 156 156 74.50 78.00 78.00 78.00 
4 133 144 146 146 66.50 72.00 73.00 73.00 
5 114 121 122 122 57.00 60.50 61.00 61.00 
         b. Bottom 
200 
candidates 
 
        Simulation 
set HS MS LS VLS 
S % 
(HS) 
S % 
(MS) 
S % 
(LS) 
S % 
(VLS) 
1 97 109 109 111 48.50 54.50 54.50 55.50 
2 69 84 87 93 34.50 42.00 43.50 46.50 
3 34 41 42 44 17.00 20.50 21.00 22.00 
4 26 30 36 40 13.00 15.00 18.00 20.00 
5 40 49 52 53 20.00 24.50 26.00 26.50 
Table 3.6: ACValidator results summary for a. top 200 and b. bottom 200 circRNAs 
in the simulation dataset. The top and bottom 200 candidates are defined in terms of the 
number of supporting reads. HS, high stringency; MS, medium stringency; LS, low 
stringency; VLS, very low stringency; S sensitivity 
 
We next evaluated ACValidator using non-simulated datasets generated from 
tissues or cells and that are summarized in Table 3.2. Since we do not know the true 
positive candidates for these datasets, we validated those circRNAs that were called in 
both the RNase R treated and non-treated datasets using six existing circRNA detection 
algorithms, find_circ, CIRI, Mapsplice, KNIFE, DCC and CIRCexplorer. Using SRPBM 
values, we selected those candidates that were called by at least three of the six tools, 
common across the treated and non-treated samples and not depleted of linear RNAs 
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using RNase R (Chapter 2, Methods).  Overall, except for the SRR1636986-SRR1637090 
pair, over 89% of the candidates that were common across the treated-non-treated pairs 
were not depleted. Among these non-depleted candidates, ACValidator was able to 
construct contigs for more than 75% of them for the RNase R treated samples and 47-
56% of the candidates for the non-treated samples (Table 3.7). This increased validation 
rate for the treated samples is expected since RNase R treatment enriches the majority of 
the circRNA species and hence they have a higher number of back-splice junction 
supporting reads. Figure 3.5 shows two examples of circRNAs validated by ACValidator 
in the treated and non-treated pairs.
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Dataset 
# overlap 
with pair 
# not 
depleted  
#  
validated 
HS 
# 
validated 
MS 
# 
validated 
LS 
# 
validated 
VLS 
HS% MS% LS% VLS% 
SRR1636985  1356 1243 918 982 990 996 73.85 79.00 79.65 80.13 
SRR1637089 1356 1243 559 620 628 642 44.97 49.88 50.52 51.65 
SRR1636986 780 594 481 510 516 520 80.98 85.86 86.87 87.54 
SRR1637090 780 594 287 328 334 336 48.32 55.22 56.23 56.57 
SRR444974 953 864 777 795 799 802 89.93 92.01 92.48 92.82 
SRR444655 953 864 461 492 494 509 53.36 56.94 57.18 58.91 
           MG_1 1806 1691 1212 1308 1319 1331 71.67 77.35 78.00 78.71 
MG_5 1806 1691 699 825 840 852 41.34 48.79 49.67 50.38 
MG_2 1430 1331 928 1013 1020 1029 69.72 76.11 76.63 77.31 
MG_6 1430 1331 537 626 634 649 40.35 47.03 47.63 48.76 
MG_3 1292 1148 808 871 882 892 70.38 75.87 76.83 77.70 
MG_7 1292 1148 511 590 599 615 44.51 51.39 52.18 53.57 
 
Table 3.7: Summary of ACValidator results on non-simulated datasets. Overlap with pair indicates the number of circRNAs 
common between the treated and untreated pairs and # not depleted is the count of circRNAs from the overlap whose SRPBM does 
not decrease following enrichment. HS%, MS%, LS% and VLS% indicate the percentage of candidates validated using high 
stringency, medium stringency, low stringency and very low stringency cut-offs.
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a) 
 
 
Figure 3.5: IGV screen shots of two circRNA candidates validated by ACValidator on RNAse R treated and non-treated samples (panel a 
shown) 
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b) 
 
 
Figure 3.5: IGV screen shots of two circRNA candidates validated by ACValidator on RNAse R treated and non-treated samples (a. 
11:117,023,156-117,034,608 and b. 9:79,829,244-79,842,401) In both screenshots, the top panel is the trinity BAM from the RNAse R treated 
sample and the bottom panel is the non-treated sample. Arrows indicate the trinity constructed contigs that cross the circRNA junction of interest 
(the junction itself is at position 300 and are indicated by double lines in the center of the contig, the arrows indicate the contig generated that 
crosses the junction)
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4.3 Computational cost overview 
As expected, the computational cost of our approaches directly correlates with the 
sequencing depth of the input sample. With respect to DeFuCir, the main rate-limiting 
step is running trinity assembly. We observed that on an eight core high performance 
computing cluster, trinity ran for an average of two days on files of size 16 GB (read 
1+read 2 FASTQs). Following trinity, the custom python post-processing scripts 
consume less than 10 minutes to complete per sample. As for the validation workflow, 
the only rate- limiting step is BWA-MEM alignment, which is performed prior to starting 
this workflow. The python validation script following this step takes less than 2 minutes 
to run for one sorted BAM file of approximately 8 GB, thus making this approach highly 
computationally efficient.  
 
4.4 Conclusions 
In this study, we present two novel computational workflows DeFuCir and 
ACValidator, both of which address two informatics challenges associated with existing 
detection methods. Firstly, though several circRNA detection tools have been developed, 
these alignment based methods only look for the presence of reads supporting the back-
spliced junction. However, obtaining the full length circRNA sequences will be valuable 
for enabling further functional analyses aimed at elucidating alternative splicing 
mechanisms in circRNAs. We developed DeFuCir, an assembly based workflow for the 
detection of full length circRNAs, which leverages soft-clipping signals in an alignment 
file. Though DeFuCir detects a smaller number of candidates, it achieves improved 
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precision in that the majority of the candidates it detects are true positives. We thus 
propose DeFuCir as an approach that can complement existing methods by filtering for 
high confidence candidates that overlap between the two and by obtaining full length 
circRNA sequences. In order to implement an unbiased approach to circRNA detection, 
DeFuCir uses only minimal filtering thresholds, and hence, repeat regions or single 
nucleotide variants (SNVs) in overlapping regions are currently not accounted for in our 
pipeline. 
Secondly, in order to address the issue of diverse results from these existing tools, 
we present ACValidator, a novel bioinformatics workflow that can validate candidate 
circRNAs of interest and help distinguish true positive candidates. When different 
circRNA detection tools identify different circRNA candidates, ACValidator will be 
helpful in narrowing down specific candidates of interest. Further, this can also serve as a 
circRNA candidate selection tool for experimental validations or functional studies. 
ACValidator achieves better performance with higher circRNA coverage when assessed 
on simulated datasets. Additionally, when tested on RNAse R treated and non-treated 
datasets, we observe that the RNAse R treated samples achieved a higher validation rate 
due to enrichment. The different overlap stringency thresholds help to assess whether 
validation approaches reach saturation and also helps ensure we capture as many 
validations as possible, while still accounting for the extent of overlap for each of them.  
As discussed in Chapter 2, continued development of novel approaches, including 
implementation of statistical tests to estimate false discovery rates in circRNA detection, 
are needed. Further, progress in understanding the biology of circRNAs will be necessary 
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for such algorithmic development. For example, existing tools do not consider gene 
fusion circRNAs but recently Guarnerio et al. [90] demonstrated that gene fusion derived 
circRNAs may play a potential role in cancer pathogenesis. Such findings will be crucial 
not only for functional analysis, but also in the development of more accurate circRNA 
detection algorithms that account for such events. 
 
5. Summary 
 We developed two novel assembly based workflows, DeFuCir and ACValidator 
that aim to address some of the informatics challenges associated with current circRNA 
detection methods. DeFuCir is an assembly based workflow that constructs full length 
circRNA contigs that represent potential full length circRNA sequences based on the 
presence of back-splicing evidence. Although DeFuCir achieves lower precision 
compared to existing tools, we propose this as an approach that can complement existing 
approaches to detect full length ensemble circRNA candidates. ACValidator is an in 
silico validation strategy that can be used to confirm the existence of a circRNA junction 
based on assembled contigs that cross over the junction. ACValidator achieves high 
precision and sensitivity with higher circRNA coverage as well as in RNAse R enriched 
datasets. Further, ACValidator can be used as a candidate selection strategy for 
experimental validation of circRNAs. These two assembly based approaches introduce a 
novel perspective to current circRNA detection methodologies. 
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CHAPTER 4 
CIRCULAR RNAS IN FUNCTIONALLY DISTINCT REGIONS OF HEALTHY 
AGED HUMAN BRAIN 
Abstract 
 CircRNAs, a recently characterized species of non-coding RNAs, are both highly 
conserved and abundant in the mammalian brain. In this study, we systematically identify 
and characterize them in circRNA-enriched RNAseq data from five functionally distinct 
regions of the human brain, including cerebellum (BC), inferior parietal lobe (IP), middle 
temporal gyrus (MG), occipital cortex (OC) and superior frontal gyrus (SF) (N = 20 total 
samples, four from each regions). Overall, over 25,000 circRNAs were detected across all 
the regions, among which 4,528 were identified by at least three of the six circRNA 
detection tools used, and in all four samples from a region. We also identified 
differentially expressed circRNAs in each brain region compared to all other regions, for 
which potential circRNA-miRNA-mRNA regulatory networks were delineated. Ingenuity 
pathway analysis on genes from these networks identified several nervous system related 
functions and pathways specific to each region, indicating that circRNAs could be 
involved in such key functions. Further, we identify a list of high-confidence full length 
circRNAs which are detected by both DeFuCir as well as exiting tools. Among these, 
circRNAs from the RIMS gene was detected in four of the five brain regions with 
SRPBM values > 2000. Lastly, using ACValidator, we perform in silico validation of 
~45% of differentially expressed circRNAs in each region, and over 80% of circRNAs 
called by all the existing tools in all samples from a region. 
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1. Background 
Circular RNAs (circRNAs) represent a species of non-coding RNAs that have yet 
to be well characterized and are formed when a downstream splice donor splices to an 
upstream splice acceptor. It has been recently demonstrated that they regulate 
microRNAs (miRNAs), preventing them from binding to their target mRNAs, as well as 
act as decoys to RBPs. Further, recent studies have reported preferential back splicing of 
neural genes and an abundance of circRNAs in the mammalian brain. Rybak-Wolf et al. 
[20] analyzed human and mouse neuronal cell line data and found that circRNAs are 
highly abundant in the mammalian brain compared to other analyzed tissues such as 
lungs, heart, kidney, testis and spleen, with well-conserved sequences. They also found 
that circRNAs were upregulated during neuronal differentiation and development, and 
highly enriched in synapses, independent of their corresponding linear isoform. In a 
separate study, analysis of RNAseq data from mouse brain, liver, heart, lung and testis 
revealed that although circRNAs were present in all the examined tissues, their 
abundance was highest in the brain. Further, 20% of the protein coding genes in the brain 
were found to produce circRNAs and encode for proteins involved in several synapse-
related functions. The study also found an enrichment of circRNAs compared to their 
host linear transcripts in synaptosomes and microdissected neuropils from mouse 
hippocampal slices [22]. 
Given the high abundance of circRNAs in the brain, there is a growing interest in 
the role of circRNAs in neurological diseases. Recently, Lukiw [32] reported reduced 
levels of circRNA ciRS-7 and a dysregulated ciRS-7-miR7 system in the hippocampal 
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CA1 region of Alzheimer’s disease (AD). However, functional studies still need to be 
performed to elucidate the role of ciRS-7 in AD and other neurological conditions.   
In this study, we aim to systematically identify and characterize circRNAs in five 
functionally distinct regions of healthy aged human brain including the cerebellum (BC), 
inferior parietal lobe (IP), middle temporal gyrus (MG), occipital cortex (OC) and 
superior frontal gyrus (SF). We further identify circRNAs from other tissue types 
including lung (LU), liver (LV), lymph node (LN) and pancreas (PA) and compare their 
abundance to that of brain circRNAs. Given the miRNA regulatory function of 
circRNAs, we further aim to evaluate their predicted impact on regulatory networks in 
each brain region using in silico methods.  
We thus performed next generation RNA sequencing (RNAseq) of RNase R 
(ribonuclease R) treated total RNA and describe for the first time brain region specific 
circRNA expression using circRNA-enriched datasets. Using these analyses, we establish 
a reference of circRNA expression profiles and regulatory networks in healthy elderly 
individuals in a region-specific manner. This resource along with existing databases such 
as circBase will be invaluable in advancing circRNA research and furthering our 
understanding of their role in transcriptional regulation in the brain and as well as in other 
neurological processes and conditions. 
 
2. Hypothesis 
We hypothesize that there are unique circRNA expression profiles in the five functionally 
distinct brain regions: BC, IP, MG, OC and SF. Further, we also hypothesize that these 
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circRNAs regulate miRNAs that in turn regulate mRNAs involved in functions specific 
to each brain region. 
 
3. Results and discussion 
3.1 Overall circRNA detection results 
20 RNAseq libraries were sequenced from five brain regions across four separate 
subjects to generate a median of 98,416,405 reads across all samples. Sequencing 
summary metrics are summarized in Table 4.1. On the FASTQ files generated from 
sequencing, we ran six circRNA prediction algorithms and detected a union of 28,220 
circRNAs across all samples with at least two supporting reads each (tool-wise 
breakdown of all detected circRNAs are summarized in Figure 4.1a). Among these, 752, 
3496, 355, 1357 and 3478 were called by at least three of the six tools in all four samples 
in BC, IP, MG, OC and SF, respectively (Figure 4.1b; henceforth referred to as our list of 
“high confidence” circRNAs). CDR1as, the widely reported circRNA, was detected by 
two of the tools - DCC and find_circ, with a median of 539 supporting reads across all 
samples. 
The majority of the identified high-confidence circRNAs map to the CDS (coding 
DNA sequence) and intronic regions, while a small percentage also map to intergenic and 
3’ untranslated (UTR) regions (Table 4.2). Further, over 88% candidates in all regions 
contained two to ten exons per circRNA whereas 3% or less had 10 or more exons. 
CircRNAs 10:116,879,948-117,309,046 (chromosome:start_coordinate-end_coordinate) 
from gene ATRNL1 (attractin-like 1) and 2:55,040,368-55,155,888 from gene EML6 
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(echinoderm microtubule associated protein like 6) had the highest number of exons - 26. 
However, it needs to be noted that these tools focus on junction-supporting reads only 
and hence may not account for alternative splicing events, as discussed in Chapter 3.
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Sample 
ID 
Total reads  
Total reads after 
UMI processing 
Mapped 
reads 
Mapped 
reads % 
rRNA 
% 
mRNA 
% 
Intronic reads 
% 
Intergenic 
reads % 
BC_1  110,166,426   107,208,904   96,842,861  90.33 2.27 44.89 43.08 9.82 
BC_2  114,951,534   111,833,362   100,749,352  90.09 0.68 33.51 45.74 20.09 
BC_3  98,639,608   96,125,856   83,742,083  87.12 0.25 7.98 47.46 44.32 
BC_4  100,710,470   96,277,094   80,376,250  83.48 0.15 5.41 49.30 45.15 
IP_1  101,386,268   98,656,506   88,348,693  89.55 6.79 48.29 31.74 13.37 
IP_2  117,002,834   113,595,746   101,666,810  89.50 3.40 49.60 34.47 12.61 
IP_3  132,785,312   128,781,536   113,670,893  88.27 1.88 48.04 28.50 21.63 
IP_4  98,769,292   95,981,446   85,452,117  89.03 1.62 33.89 36.57 27.95 
MG_1  111,473,936   107,609,934   96,300,242  89.49 3.79 53.06 33.12 10.12 
MG_2  99,559,694   96,840,790   86,560,619  89.38 6.17 46.80 33.44 13.75 
MG_3  114,053,720   111,576,344   100,264,691  89.86 1.05 24.15 41.35 33.47 
MG_4  103,003,950   100,539,028   88,511,086  88.04 0.26 8.11 48.07 43.57 
OC_1  90,848,494   88,547,042   80,250,817  90.63 5.22 45.81 37.56 11.54 
OC_2  124,200,016   120,983,142   107,386,487  88.76 6.35 49.13 31.99 12.67 
OC_3  105,523,894   102,655,452   92,080,615  89.70 4.36 43.00 29.95 22.75 
OC_4  112,150,858   108,449,330   94,107,535  86.78 0.22 10.34 47.67 41.78 
SF_1  90,538,780   87,621,824   78,534,192  89.63 3.10 52.60 32.88 11.49 
SF_2  149,529,412   145,057,894   128,027,756  88.26 6.94 53.86 27.30 12.05 
SF_3  112,711,442   110,152,030   99,860,423  90.66 1.27 32.19 36.38 30.18 
SF_4  100,082,932   96,724,472   84,749,793  87.62 0.54 29.84 40.47 29.16 
 
Table 4.1: RNAseq summary metrics. UMI processing performed as described in Methods. UMI, Unique molecular indexes.
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a  b      
c        d  
e    f  
Figure 4.1: Summary of circRNA prediction results. (a) Tool-wise breakdown of circRNA 
detection across all brain regions; (b) Number of circRNAs called by at least three of six tools in 
all four samples; (c), (d), (e) Chromosomal, size and read count distribution of circRNAs called 
by at least three of six tools in all four samples (f) Intersection across regions of circRNAs called 
by at least three of six tools in all four samples; the green bar indicates the number of circRNAs 
called in all five regions. BC, cerebellum; IP, inferior parietal lobe; MG, middle temporal gyrus; 
OC, occipital cortex; SF, superior frontal gyrus 
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Region 
CircRNA 
count 
CDS 5'UTR 3'UTR Intronic Intergenic 
BC 752 739 234 70 695 8 
IP 3496 3418 1056 393 3290 31 
MG 355 347 120 31 329 5 
OC 1357 1332 412 144 1285 12 
SF 3478 3410 1049 388 3296 23 
 
Table 4.2: Summary of genomic region(s) of origin for high confidence 
circRNAs. CircRNA count is the number of circRNAs called by three of six  
tools in all four samples of that region. 
 
We also observed in all brain regions that over 10% of the circRNAs map to 
chromosome 1, the longest chromosome, and <=1% circRNAs map to chromosomes 21 
and 22 (Figure 4.1c). This is consistent with previous findings that the number of 
circRNAs detected is proportional to the length of the chromosome [26]. Further, the size 
distribution of all high confidence circRNAs spans a wide range between 129 and 
432,649 bp  (Figure 4.1d). 
CircRNA abundance is quantified by the number of reads spanning the back-
spliced junction. While 76% (7,189/9,438) of our list of high confidence circRNAs were 
supported by an average of only two to 20 reads, 214 circRNAs had an average of over 
100 supporting reads, among which four were over 500 (Figure 4.1e). Further, to 
normalize for library size, we calculated the spliced reads per billion mapping (SRPBM) 
as described in [20] (Methods). 
We next evaluated the extent of overlap among these high confidence circRNAs 
between the different brain regions (Figure 4.1f). We observed that 192 circRNAs were 
common across all five brain regions, while 69, 864, 4, 43 and 762 were unique to BC, 
IP, MG, OC and SF respectively. After accounting for these overlaps, there were 4,528 
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unique high confidence circRNAs across all the regions. The most abundant circRNAs 
that were common across all brain regions include 1:117,944,807-117,963,271, from 
gene MAN1A2 (mannosidase alpha class 1A member 2), supported by an average 
SRPBM of 5,093 and 6:73,016,960-73,043,538, from gene RIMS1 (regulating synaptic 
membrane exocytosis 1), supported by an average SRPBM of 4,631 across all the 
regions. Among the unique circRNAs, 16:31,230,415-31,230,840 from gene TRIM72 
(tripartite motif containing 72) in BC (Average SRPBM = 1100), 12:116,668,337-
116,675,510 from gene MED13L (mediator complex subunit 13 like) in IP (Average 
SRPBM = 425.36), 3:170077486-170079217 from gene SKIL (SKI like proto-oncogene) 
in MG (Average SRPBM = 128.22), X:128250586-128256170 in OC (intergenic; 
Average SRPBM = 150.17) and 1:169947225-170001116 from gene KIFAP3 (kinesin 
associated protein 3) in SF (Average SRPBM = 426.11) were the most abundant. 
Comparing our catalog of high confidence circRNAs with circBase, we observed that 
67% (3,035/4,528) have been reported in at least one of the four studies deposited in the 
database; these studies evaluated various cell lines and tissue types, including cerebellum, 
diencephalon, SH-SY5Y cells, Hs68 cells, HeLa cells and HEK293 cells. 
In order to compare circRNA abundance between different tissue types, we 
further sequenced 17 RNase R treated and rRNA depleted RNAseq libraries from the 
lung (LU, N= 3), liver (LV, N = 6), lymph node (LN, N = 4) and pancreas (PA, N = 4). 
We generated a median of 100,467,680 reads across all samples with an average mapping 
percentage of 84%. Applying the same analytical pipeline as above, we identified a total 
of 17,165 unique circRNAs across all samples, the majority of which were present in 
   82 
only one of the samples in the respective tissue type. Comparing the number of circRNAs 
called by at least three of the six tools in each sample between our brain and other tissue 
type datasets, we observe a much higher abundance of brain circRNAs, as also reported 
in previous studies [20] (Figure 4.2). Upon filtering for circRNAs identified in all the 
samples by at least three of the six tools in a tissue type, 14, 5, 4 and 3 circRNAs were 
detected in LN, LU, PA and LV, respectively. Comparing these circRNAs with the high 
confidence circRNAs from the brain, we observe that 4,510 circRNAs were unique to the 
brain. Three circRNAs were present only in the lymph node- 7:117,825,700-117,828,459 
from LSM8 (LSM8 homolog, U6 small nuclear RNA associated), 7:50,358,643-
50,367,353 from IKZF1 (IKAROS family zinc finger 1) and 16:30,495,147-30,495,584 
from ITGAL (integrin subunit alpha L) and one circRNA, 19:10,183,599-10,184,111 
from C3P1 (complement component 3 precursor pseudogene) was unique to the liver. 
Notably, previous studies have found abundant expression of the linear isoforms of these 
genes in the lymph node and liver [91, 92]. 
 
   83 
 
Figure 4.2: CircRNAs detected in brain vs. other tissue types. Other tissue types 
evaluated include LN, LU, LV and PA. LN, lymph node; LU, lung; LV, liver; PA, 
pancreas 
 
 
3.2 Region specific differential expression analysis and regulatory network 
prediction 
Given the presence of abundant circRNAs in the brain, we asked if these brain 
circRNAs were expressed in a region specific manner. Using DESeq2, we identified 
differentially expressed (DE) circRNAs in each brain region compared to all other 
regions (Table 4.3, Figure 4.3). In the BC, 1,064 circRNAs were differentially expressed 
(corrected P < 0.01). 351 of these candidates also had a log2(fold change) > 3 or < -3. 
Fewer DE circRNAs were identified in the other four regions compared to BC (Table 
4.3). We performed Ingenuity pathway analysis (IPA) on the genes from which these DE 
circRNAs arise. Our input genes were enriched in several neuronal and nervous system 
related functions and pathways commonly across all the regions. Examples include 
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neuropathic pain signaling in dorsal horn neurons, neuritogenesis, synaptic transmission, 
morphology of the brain, excitatory post-synaptic potential and quantity of synaptic 
vesicles. 
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Region 
# of DE 
circRNA
s 
# unique 
circRNA-
miRNA 
interactions 
# unique 
circRNAs 
# unique 
miRNAs 
# interactions 
with > 20 
binding sites 
# circRNAs 
in network 
# miRNAs 
in network 
# genes in 
network 
BC 1064 13887 1053 1377 253 71 21 1142 
SF 93 1377 92 524 14 7 5 312 
MG 99 1431 98 517 11 11 6 393 
OC 113 1244 110 374 28 2 2 65 
IP 106 2054 106 635 29 10 10 334 
Table 4.3: Summary of differentially expressed (DE) circRNAs and network analysis. DE cut off: uncorrected  
P < 0.05 for all regions except BC; corrected p-value < 0.01 for BC (N = 1,923 DE circRNAs with uncorrected  
P < 0.05). There were no circRNAs in IP, MG, OC and SF with corrected P < 0.01 or 0.05.
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a.  
b.  
Figure 4.3: Heatmaps of differentially expressed (DE) circRNAs (BC and SF maps 
shown) 
Heatmap for BC; DE genes with corrected P < 0.01 (N = 1064 circRNAs); All 4 samples 3 tools
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Heatmap for SF; DE genes with p < 0.05 (N = 93 circRNAs); 4 Samples 3 tools
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Figure 4.3: Heatmaps of DE circRNAs (MG and OC maps shown) 
Heatmap for MG; DE genes with p < 0.05  (N = 99 circRNAs); All 4 Samples, 3 tools
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Heatmap for OC; DE genes with p < 0.05 (N = 113 circRNAs); 4 Samples, 3 tools
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e.  
Figure 4.3: Heatmap of DE circRNAs (IP map shown) 
 
Using miRNA target prediction algorithms, miRNA targets of DE circRNAs in 
each brain region were predicted (Methods). Using a list of 2,588 published miRNAs 
from miRBase, we detected more than 1000 unique interactions between circRNAs and 
miRNAs predicted by both algorithms in each region (Table 4.3). The identified 
interactions represent binding sites for miRNAs on each circRNA candidate, predicted 
based on complementarity in the miRNA seed region (nucleotide positions 2-7 in the 
miRNA 5’-end). Interestingly, the unique interactions in each region were predicted to be 
between approximately 370 to 1370 unique miRNAs and approximately 90 to 1050 
unique circRNAs in our input list, indicating that a single miRNA may bind several 
Heatmap for IP; DE genes with p < 0.05 (N = 106 circRNAs); All 4 samples, 3 tools
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different circRNAs and vice-versa. Further, among all the interactions detected, a small 
percentage was predicted by the miRanda algorithm to have 20 or more putative binding 
sites (Table 4.3).  
MiRNAs are well known regulators of mRNAs and several databases have 
compiled predicted miRNA-mRNA interactions. We thus further employed the list of 
miRNA-mRNA interactions common in two databases: miRTarBase and TargetScan, to 
determine the target genes for our predicted miRNAs. Overall there were more than 300 
unique target genes predicted for miRNAs in all regions except for the OC, which had 65 
predicted target genes. By compiling all predicted miRNAs that may be regulated by 
identified circRNAs, as well as mRNAs that may be regulated by those miRNAs, we 
constructed circRNA-miRNA-mRNA regulatory networks for each brain region (Figure 
4.4).  
Lastly, we ran IPA to predict enriched pathways and functions among the 
predicted target genes in each region. Our analysis revealed significant enrichment 
(uncorrected p-value < 0.05) of several nervous system developmental functions, the 
majority of which were common across all the brain regions. Some of the common 
enriched functions include morphology of nervous system, brain size and formation, 
development, morphology and proliferation of neurons, synaptic plasticity, proliferation 
of neuroglia, Schwann cells and neuroblasts, and long-term potentiation. Genes 
associated with these functions include NFIB (nuclear factor I B), PTEN (phosphatase 
and tensin homolog), NF1 (neurofibromin 1), BACE1 (beta-secretase 1), ITSN1 
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(intersectin 1), CHRM3 (cholinergic receptor muscarinic 3) and AKAP5 (A kinase 
anchoring protein 5).  
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a.  
Figure 4.4: Predicted circRNA-miRNA-mRNA regulatory network (BC) 
Red circular nodes: circRNAs, green triangular nodes: miRNAs, blue square nodes: genes. mRNA, messenger RNA 
(For the BC, only the top 50 up and downregulated circRNAs are depicted in the network for clearer visualization) 
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b.  
Figure 4.4: Predicted circRNA-miRNA-mRNA regulatory network (IP) (All predicted miRNAs/mRNAs depicted) 
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c.  
Figure 4.4: Predicted circRNA-miRNA-mRNA regulatory network (MG) (All predicted miRNAs/mRNAs depicted) 
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d.  
 
Figure 4.4: Predicted circRNA-miRNA-mRNA regulatory network (OC) (All predicted miRNAs/mRNAs depicted) 
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e.  
Figure 4.4: Predicted circRNA-miRNA-mRNA regulatory network (SF) (All predicted miRNAs/mRNAs depicted)
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Further, IPA also identified several pathways that were commonly enriched 
across the different brain regions (uncorrected P < 0.05; Appendix Tables 4.1 - 4.10). 
These common pathways include neuroinflammation signaling pathway associated with 
genes such as TRAF3 (TNF receptor associated factor 3), PIK3CA (phosphatidylinositol-
4,5-bisphosphate 3-kinase catalytic subunit alpha), BDNF (brain derived neurotrophic 
factor) and AKT1 (AKT serine/threonine kinase 1), axonal guidance signaling associated 
with genes including TUBB (tubulin beta class I), MAPK1 (mitogen-activated protein 
kinase 1), DPYSL2 (dihydropyrimidinase like 2) and GSK3B (glycogen synthase kinase 3 
beta), NGF (nerve growth factor) signaling associated with PI3Ks (phosphoinositide-3-
kinases) - PIK3CA (PI3K, catalytic, alpha polypeptide), PIK3R1 (PI3K, regulatory 
subunit 1 (alpha)), MAPK1 and MAP3K2 (MAP kinase kinase kinase 2), amyloid 
processing associated with BACE1, GSK3B, MAPK1 and CSNK2A1 (Casein Kinase 2 
Alpha 1), AMPK signaling associated with ARID1A (AT-rich interaction domain 1A), 
AK2 (adenylate kinase 2), CHRM3 and RAB6A (RAB6A, member RAS oncogene 
family), and neuregulin signaling associated with PTEN, NRG1 (Neuregulin 1), kinases 
MAP2K1 (MAP kinase kinase 1), MAPK1 and PRKCE (protein kinase C epsilon).  
IPA on each region also predicted a few functions and pathways that were unique 
to that region. The BC is posterior to the brain stem, and receives information from the 
sensory systems, spinal cord, and other parts of the brain to regulate motor movements. 
One of the pathways identified uniquely in BC was the NF-kB (nuclear factor kappa B) 
signaling pathway (uncorrected P=0.00003). This is consistent with previous findings 
that identified constitutive NF-kB activity in rodent brain regions including the 
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cerebellum [93]. NF-kB is required for cerebellar granule neurons survival [94] as well as 
plays crucial roles in the nervous system such as long term response to synaptic 
plasticity, survival and apoptosis of neurons [95, 96]. 26 genes from our input list were 
associated with this pathway and include the PI3Ks PIK3CA and PIK3R1, which are 
responsible for coordinating cell functions such as proliferation and survival, MAPK 
genes such as MAP3K7 (MAP kinase kinase kinase 7), MAP2K7 (MAP kinase kinase 7) 
and MAP3K1 (MAP kinase kinase 1). Other genes in this pathway include AKT1, RELA 
(RELA proto-oncogene, NF-kB subunit), GSK3B and TRAF6 (TNF receptor associated 
factor 6). Other enriched pathways include IL-3 (Interleukin-3) and IL-6 (Interleukin-6) 
signaling, neuropathic pain signaling in dorsal horn neurons and reelin signaling in 
neurons (Appendix Tables 4.1, 4.2). 
The SF is located at the superior aspect of the prefrontal cortex and constitutes 
about one-third of the frontal lobe in the human brain. It is involved in executive 
functions including self-awareness, working memory, and attention [97]. Among the DE 
circRNAs in this region, the ones mapping to PLCH1 (Phospholipase C Eta 1), AAK1 
(AP2 Associated Kinase 1) and RIMS2 (Regulating Synaptic Membrane Exocytosis 2) 
had the highest fold changes.  IPA on the 312 genes in the circRNA-miRNA-mRNA 
network identified 92 enriched pathways and 217 nervous system developmental 
functions (uncorrected P < 0.05). Among the enriched pathways, the ones unique to this 
region include the Wnt/Ca+ pathway, actin nucleation by ARP-WASP (actin related 
protein-Wiskott-Aldrich syndrome protein) complex and cell cycle control of 
chromosomal replication. Wnt/Ca2+ and Wnt/β-catenin pathways participate in pre- and 
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post-synaptic receptor localization as well as neuronal pathfinding [98]. Genes associated 
with this pathway include DVL2 (Dishevelled Segment Polarity Protein 2), FZD6 
(Frizzled Class Receptor 6), SMO (Smoothened, Frizzled Class Receptor) and GSK3B. 
While functions such as formation of the forebrain, branching of neurites, axonogenesis, 
long term potentiation of hippocampal CA1 region were enriched in SF as well as other 
brain regions, a few functions were also uniquely enriched in the SF, including 
proliferation of neural precursor cells, outgrowth of axons, formation of dendritic spines, 
and migration of neuroglia (Appendix Tables 4.3, 4.4).   
The MG is located in the temporal lobe between the superior and inferior 
temporal gyri and is involved in face recognition, ascertaining distance, memory and 
emotion. DESeq2 analysis revealed that circRNAs from DNAH7 (dynein axonemal heavy 
chain 7), NSUN6 (NOP2/Sun RNA methyltransferase family member 6), EPHX2 
(epoxide hydrolase 2), and AKAP7 (A-Kinase anchoring protein 7) had the highest fold 
changes. IPA analysis on genes from the circRNA-miRNA-mRNA network identified 86 
significantly enriched pathways and 164 nervous system developmental functions 
(uncorrected p-value < 0.05) (Appendix Tables 4.5, 4.6).  Among these, synaptic long 
term potentiation, glutamate receptor signaling and glutamine biosynthesis were uniquely 
identified in the MG. Long term potentiation is one of the major cellular mechanisms 
underlying synaptic plasticity as well as learning and memory. A few other genes 
associated with this pathway from our input list include CALM1 (calmodulin 1), which 
encodes for a calcium binding protein, GRM3 (Glutamate Metabotropic Receptor 3) 
which encodes G protein coupled receptor proteins and is involved in most aspects of 
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normal brain functions, EP300 (E1A Binding Protein P300) which encodes the 
adenovirus E1A-associated cellular p300 and PRKCD (Protein Kinase C Delta) whose 
encoded protein is a positive regulator of cell cycle progression. Further, the 
neurodevelopmental function differentiation of oligodendrocyte precursor cells were also 
identified uniquely in MG.  
The OC is located at the dorsal aspect of the brain, behind the temporal and 
parietal lobes, and is primarily responsible for processing visual information. Among the 
DE circRNAs in this region, 81% were downregulated compared to all other regions. IPA 
analysis on genes from the circRNA-miRNA-mRNA network identified significant 
enrichment in 45 pathways and 52 nervous system developmental functions (uncorrected 
P < 0.05) (Appendix Tables 4.7, 4.8). This is relatively lower compared to other regions 
due to the smaller number of genes identified in the network analysis. Some of the 
functions identified in this region that were also present in other regions include 
myelination, synaptic plasticity, proliferation of neurons and activation of neuroglia, 
associated with genes including ATN1 (Atrophin 1), NF2 (Neurofibromin 2), CLU 
(Clusterin), BCKDK (Branched Chain Ketoacid Dehydrogenase Kinase) and FGF1 
(Fibroblast Growth Factor 1). Apart from the common functions and pathways identified 
in this region, a few unique pathways such as glycogen biosynthesis, histidine 
degradation, and folate transformations were also identified.   
The IP lies below the horizontal portion of the intraparietal sulcus and is involved 
in the perception of emotions in facial stimuli, interpretation of sensory information and 
language and mathematical operations. 63 of the 106 DE circRNAs in this region 
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demonstrated a positive fold change (uncorrected P < 0.05). IPA on the 334 genes from 
the network revealed significant enrichment of 114 pathways and 162 
neurodevelopmental functions (uncorrected P < 0.05) (Appendix Tables 4.9, 4.10). 
Several of the identified pathways and functions were also identified in other regions 
including neuroinflammation signaling pathway, axonal guidance signaling, and IL-7 
signaling pathways. Further, pathways including sonic hedgehog signaling, OX40 
signaling pathway and the role of p14/p19ARF in tumor suppression were uniquely 
identified in IP.  
 
3.3 Assembly based detection of circRNAs 
We next applied DeFuCir, the assembly based detection approach described in 
Chapter 3 on these samples. Our de novo approach detected 10,000 to 67,000 circRNA 
contigs across the samples, with a median of 25,860 (Table 4.4). Compared with 
candidates identified by six existing circRNA detection tools and allowing a 10 bp 
window for the match (Methods), we observed only about 6% overlap between the two 
approaches. However, for these 6% of overlapping candidates, the full-length sequences 
of the circRNA transcripts are constructed using trinity assembly. We hence report these 
overlapping candidates as our list of high-confidence full length circRNAs.  
Among these overlapping circRNA candidates, 6:73005639-73043538 in the BC 
from gene RIMS1 (SRPBM = 30037.4), 6:54013853-54067031 in the IP from gene MLIP 
(Muscular LMNA Interacting Protein; SRPBM = 3992.89), 6:73016960-73043538 in the 
SF and OC from RIMS1 (SRPBM = 3712.74 in SF, 3703.26 in OC) and 8:105080739-
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105161076 in the MG from RIMS2 (SRPBM = 2488.05) demonstrated the highest 
expression in terms of SRPBMs.  
 
Sample 
ID 
Total number 
of contigs 
from trinity 
# of contigs with 
back-spliced soft 
clipping signals 
(circRNAs) 
Overlap with all 
candidates from 
existing 
approaches 
Overlap with 
candidates called 
by 3/6 tools from 
regular approach 
BC_1 715,292 18,667 2265 1544 
BC_2 1,015,381 30,785 2195 1576 
BC_3 1,342,745 52,276 597 422 
BC_4 1,260,320 67,798 309 197 
IP_1 409,760 10,844 1573 945 
IP_2 575,742 15,150 1723 1111 
IP_3 926,497 29,065 1348 920 
IP_4 885,136 30,235 1292 915 
MG_1 585,278 15,508 1745 1083 
MG_2 685,177 17,787 1130 751 
MG_3 1,288,266 41,132 836 570 
MG_4 1,267,560 46,107 129 85 
OC_1 720,260 17,308 1157 802 
OC_2 782,643 18,330 1062 737 
OC_3 768,926 22,655 1016 697 
OC_4 1,491,938 65,442 424 279 
SF_1 642,558 16,434 1380 975 
SF_2 835,582 20,501 1319 917 
SF_3 1,101,862 33,218 1015 719 
SF_4 917,800 34,167 1266 864 
Table 4.4: Summary of DeFuCir results 
 
3.4 Assembly based in silico validation of circRNAs 
In order to in silico validate selected circRNAs, we next implemented 
CircValidator, the assembly based in silico validation approach described in Chapter 3. 
Among the differentially expressed circRNAs, we observed that on an average, 41% of 
the candidates validated with the high-stringency threshold while 46% and 47% validated 
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with the low-stringency and very-low stringency thresholds (Table 4.5a). On the other 
hand, when we applied CircValidator on candidates called by all tools in all samples, we 
observed a higher validation rate of 80% using the high-stringency threshold and 86% 
using the low-stringency threshold (Table 4.5b). These results demonstrate that an 
ensemble approach yields higher confidence circRNA results compared to using a single, 
or a few, tools, as previously reported (Hansen 2015). 
 
a) 
Sample ID # Input for validation 
# 
validated 
HS 
# 
validated 
MS 
# 
validated 
LS 
# 
validated 
VLS 
BC_1 100 47 47 47 49 
BC_2 100 42 45 47 48 
BC_3 100 36 39 39 39 
BC_4 100 33 37 37 39 
IP_1 106 55 63 64 64 
IP_2 106 46 54 56 57 
IP_3 106 45 52 54 54 
IP_4 106 47 54 54 54 
MG_1 99 48 50 50 51 
MG_2 99 49 51 53 54 
MG_3 99 41 42 43 44 
MG_4 99 10 11 11 11 
OC_1 113 42 46 46 47 
OC_2 113 36 37 37 37 
OC_3 113 42 48 48 48 
OC_4 113 18 20 21 22 
SF_1 93 52 59 60 62 
SF_2 93 52 58 59 61 
SF_3 93 44 49 50 52 
SF_4 93 50 54 55 56 
Table 4.5: Summary of ACValidator results when run on a) DE circRNAs from each 
region 
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b) 
Sample ID 
#  
Input for  
validation 
# 
validated  
HS 
#  
validated  
MS 
#  
validated  
LS 
#  
validated  
VLS 
BC_1 50 48 48 48 48 
BC_2 50 44 45 45 45 
BC_3 50 39 42 43 43 
BC_4 50 35 40 41 42 
IP_1 285 219 231 234 237 
IP_2 285 225 241 243 247 
IP_3 285 207 222 224 226 
IP_4 285 221 233 234 237 
MG_1 12 12 12 12 12 
MG_2 12 12 12 12 12 
MG_3 12 9 10 10 10 
MG_4 12 5 7 7 7 
OC_1 97 75 81 81 81 
OC_2 97 79 85 85 86 
OC_3 97 80 87 87 87 
OC_4 97 73 79 80 82 
SF_1 299 225 239 241 243 
SF_2 299 218 236 240 241 
SF_3 299 217 230 234 234 
SF_4 299 232 245 246 246 
Table 4.5: Summary of ACValidator results when run on b) circRNAs called by all 
tools in all samples in a region. HS, high stringency cut off; MS, medium stringency cut 
off; LS, low stringency cut off; VLS, very low stringency cut off 
 
4. Conclusions 
In this study, we profiled circRNA expression in five brain regions from four 
healthy aged individuals and predicted their impact on transcriptional regulatory 
networks in each region. Based on the results from ensemble circRNA detection analysis 
using six tools, we identified a total of 4,528 circRNAs that were called in all samples 
across brain regions by at least three of the six tools. While 192 circRNAs were common 
across all the regions, each region also had unique circRNAs. Some of these include 
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circRNAs mapping to MED13L, TRIM72, SKIL and KIFAP3. Among the circRNAs 
detected across all regions, RIMS1 had a high SRPBM of 4,631. The protein encoded by 
this gene regulates synaptic vesicle exocytosis and is associated with cone-rod dystrophy 
and retinitis pigmentosa. Recently, Rybak Wolf et al [20] also reported abundant 
expression of RIMS2 in their mammalian brain circRNA study.  
MiRNA target prediction analyses on differentially expressed circRNAs revealed 
1,244 to 13,887 unique circRNA-miRNA interactions across brain regions. Furthermore, 
65 to 1,142 target genes were identified for these miRNAs. IPA on the genes in each 
region’s network revealed significant enrichment of several neurodevelopmental and 
nervous system related functions and pathways. While the majority of these enriched 
ontologies were common across all regions, a few pathways and functions were also 
unique to each region.  
Using the assembly analysis workflows described in Chapter 3, we identified a 
list of high-confidence full length circRNAs, as well as in silico validated approximately 
45% of DE circRNAs and more than 80% of circRNAs called by all tools in all samples. 
Notably, the assembly based de novo detection approach identified RIMS1 and RIMS2 in 
four of the five brain regions with SRPBMs > 2000. Interestingly, a different isoform of 
RIMS1 was detected in the BC compared to those identified in the SF and OC. 
Although our study lends new insight into region specific circRNA expression 
and regulatory networks, we are limited by a few technical caveats. Primarily, while 
RNase R treatment reduces the population of linear RNAs in a sample, it is not well 
understood if this depletion step introduces any biases in circRNA detection and if this 
   105 
step has the potential to deplete circRNAs. Previous studies have reported that in some 
cases, circRNAs are sensitive to RNase R [2, 30, 42]. In order to understand whether the 
detected circRNA expression profiles are specific to healthy aged brains, deeper 
investigations using healthy younger controls as well as diseased brain samples will be 
needed. Similarly, additional cell-specific characterization of circRNAs using circRNA-
enriched datasets will help us understand whether their expression varies across cell 
types. Such analyses on the linear transcriptome in past have helped identify cell-specific 
contributions to neurological diseases such as in AD [64, 99, 100].  
Overall, our study describes circRNA expression in a brain region-specific 
manner using circRNA enriched RNAseq data and thus contributes to our understanding 
of this more newly classified class of RNAs. Through our above analyses, we have 
established a valuable reference dataset of their expression profiles in healthy elderly 
individuals for the circRNA research community. This resource, along with existing 
databases such as circBase and future experimental studies, will help us to better 
understand how and whether circRNAs represent a novel layer of transcriptional 
regulation in the brain as well as pave an avenue towards evaluating their utility in 
biomedical applications.  
 
5. Methods 
5.1 Sample acquisition 
Postmortem brain samples were collected at the Banner Sun Health Research 
Institute’s Brain and Body Donation Program from five functionally distinct brain 
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regions from six clinically normal aged subjects (protocols as described in Chapter 2). 
Total RNA extracted from the pancreas, liver, lung and lymph node tissues of four 
healthy subjects in each tissue type was purchased from Proteogenex (Culver City, CA).  
 
5.2 RNA isolation and RNase R treatment 
For the brain samples, total RNA was extracted from 100 mg of each of the brain 
regions.  Tissue was divided on dry ice into 50 mg pieces and placed in 2 mL Rino tubes 
(NextAdvance, Troy, NY) containing an equal amount of Rino beads (NextAdvance, 
Troy, NY). The tissue was homogenized by adding 300 µl of lysis buffer and then using a 
Bullet Blender (NextAdvance, Troy, NY) at speed 8 for 3 mins followed by a 
QIAshredder (Qiagen, Hilden, Germany) column that was spun for 2 mins at full speed. 
The homogenate was processed according to the mirVana miRNA isolation kit protocol 
(Thermo Fisher, Waltham, MA). The 100 µl of eluted RNA was taken into a RNA 
Cleanup and Concentrator-5 (Zymo Research, Irvine, CA), which consisted of an on-
column DNase treatment. RNA quality and quantity was measured with a NanoDrop 
1000 (Thermo Fisher, Waltham, MA) and a RNA screen tape on the 4200 Tapestation 
(Agilent Technologies, Santa Clara, CA) according to manufacturer’s protocols.  
For the RNase R treatment of both brain and other tissue type samples, RNA was 
normalized to 102.6 ng/µl (4µg of RNA in 39 ul) using nuclease-free water. In a 1.5 mL 
DNA Lo-Bind tube (Eppendorf, Hamburg, Germany), 5 µl of 10X RNase R reaction 
buffer and 6 µl of RNase R 2U/µl (Epicentre, Madison, WI) were added to the 39 µl of 
RNA. The reaction mix was pipette-mixed 10 times and then placed in a water bath for 
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10 mins at 37 °C. After incubation, the treated RNA was placed on ice and immediately 
cleaned up with the Cleanup Concentrator-5, this time without DNase treatment. The 
RNA was eluted with water and all 10 µl were transferred into a 96-well plate for library 
preparation. The sealed plate was frozen at -80 °C for up to five days before library 
preparation was started. 
 
5.3 Library preparation and paired-end sequencing 
Sequencing libraries were prepared using the Illumina TruSeq Stranded Total 
RNA Library Prep Human/Mouse/Rat Kit (Illumina, San Diego, CA) following the 
manufacturer’s protocol except where noted. For the incorporation of unique molecular 
indexes (UMIs), 5ul of 500 nM xGen Dual Index UMI Adapters (IDT, Skokie, IL) were 
used in place of the TruSeq adapters and additional re-suspension buffer. For DNA 
fragment enrichment, 8 cycles (brain samples) and 15 cycles (other organs) of PCR were 
performed. Completed libraries were quantified using the High Sensitivity DNA Screen 
tape and reagents on the 4200 Tapestation and with the Qubit dsDNA High Sensitivity 
Assay kit (Thermo Fisher, Waltham, MA). Equimolar amounts of library were pooled 
and sequenced on the HiSeq  (Illumina, San Diego, CA) to generate paired 82 bp reads. 
 
5.4 Data analysis 
Raw sequencing data in the form of basecall files (BCLs) were converted to FASTQ 
format using Illumina’s bcl2fastq conversion software and quality checked using fastQC 
[80]. FASTQs were quality trimmed to 76 bp across all samples using fastx_trimmer. 
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Since UMIs were incorporated in our samples, we first ran bwa mem on the trimmed 
FASTQs followed by UMI aware dup marking using Picard. These bams were then re-
converted to FASTQ using bedtools [83] and were then run through six different 
circRNA prediction algorithms - CIRCexplorer (v1.1.10) [42], CIRI (v2) [46], DCC 
(v0.4.4) [44], find_circ (v1) [3], Mapsplice (v2.1.8) [36] and KNIFE (v1.4) [45] using 
default parameter settings. Samples from two of the six donors were dropped from further 
analysis due to outliers in circRNA detection. CircRNAs from each sample with at least 
two supporting reads were used for further downstream processing and analyses. CIRI, 
Mapsplice and DCC produce 1-based circRNA co-ordinates, and were therefore 
converted to 0-based co-ordinates to be consistent with the other three algorithms. 
5.4.1 CircRNA normalization 
 CircRNA reads were normalized as described in Chapter 2, using the formula 
𝑆𝑅𝑃𝐵𝑀 =
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑏𝑎𝑐𝑘 − 𝑠𝑝𝑙𝑖𝑐𝑒𝑑 𝑟𝑒𝑎𝑑𝑠
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑚𝑎𝑝𝑝𝑒𝑑 𝑟𝑒𝑎𝑑𝑠
×  1,000,000,000 
5.4.2 Differential expression analysis 
DESeq2 analysis was performed on circRNA candidates detected in all four 
samples by at least three of the six tools, to identify DE circRNAs in each brain region 
compared to all other regions. We filtered for DE circRNAs with Benjamini and 
Hochberg (BH) corrected P < 0.01 for the BC, uncorrected P < 0.05 for the other regions, 
and generated expression heatmaps for the DE circRNAs. 
5.4.3 miRNA target prediction 
We next conducted miRNA binding site prediction using the miRanda [65] and 
RNAHybrid [66] algorithms on DE circRNAs with corrected P < 0.01 in the BC and 
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uncorrected P < 0.05 in all other regions (since the IP, OC, MG and SF did not have any 
circRNAs with corrected P < 0.01). MiRanda and RNAHybrid algorithms are briefly 
summarized in Chapter 2, Methods. Only those circRNA-miRNA interactions predicted 
by both the algorithms were used for downstream network construction and analyses. We 
also required the interactions to have RNAHybrid predicted minimum free energy (MFE) 
< -20 and uncorrected P < 0.05, as well as a miRanda match score >= 150.  
5.4.4 CircRNA-miRNA-mRNA network construction 
MiRNA-mRNA interactions common to both miRTarBase [69] and TargetScan 
[70] were used to determine the gene targets of each filtered miRNA from the miRNA 
target prediction analysis. Using these circRNA-miRNA and miRNA-mRNA interaction 
predictions, we outlined circRNA-miRNA-mRNA regulatory networks for each brain 
region using custom python scripts and visualized the networks using Cytoscape [68].  
5.4.5 Pathway analysis  
Using the list of mRNAs identified in the circRNA-miRNA-mRNA networks, we 
performed enrichment analysis using IPA v01-12 from Qiagen to predict 
neurodevelopmental functions and pathways enriched in the different brain regions. The 
results were filtered for functions and pathways with an uncorrected P < 0.05. 
5.4.6 Assembly based de novo detection of full length circRNAs 
We applied DeFuCir, the assembly based de novo detection workflow described 
in Chapter 3 in order to detect full length circRNA transcripts. Briefly, all UMI dup 
removed FASTQs were assembled using Trinity, followed by aligning the trinity contigs 
to GRCh37 reference genome. Custom python scripts were then run to detect contigs that 
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had evidence of back-splicing. We further compared circRNAs detected using the 
assembly approach with those from existing circRNA detection tools allowing a 10 bp 
window for the match. Specifically, we compared them against the union of circRNAs 
detected by all tools as well as circRNAs called by at least three of six tools. The 
overlapping candidates constitute our list of high confidence full length circRNAs. 
5.4.7 In silico validation of circRNAs 
ACValidator, described in Chapter 3, was run to in silico validate selected 
circRNA candidates. Briefly, given a circRNA coordinate and the input alignment file, 
circValidator extracts reads from a fixed window on either side of the circRNA junction 
and assembles those reads. The assembled contigs are then interrogated for overlap with 
the circRNA junction sequence, with different stringency cut-offs of the number of 
overlapping bases (high stringency - 30 bp, medium stringency - 20 bp, low stringency - 
10 bp and very low stringency - 5 bp overlap on either side of the junction to validate). 
Using this approach, we validated the list of differentially expressed circRNAs detected 
in each region, as well as those circRNAs called by all six tools in all four samples in a 
region.  
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6. Summary 
 In summary, we profiled circRNA expression in a brain region specific manner 
and identified circRNA candidates unique to each of the five brain regions analyzed, as 
well as common across the regions. Further, we detected differentially expressed 
circRNAs in each brain region compared to all other regions using DESeq2. MiRNA 
target prediction analysis and subsequent identification of circRNA-miRNA-mRNA 
networks was then performed on the differentially expressed circRNAs (corrected P < 
0.01 for BC, uncorrected P < 0.05 for all other regions) from each region.  Enrichment 
analysis on the genes from each region’s regulatory network identified several nervous 
system related functions and pathways that were commonly impacted as well as unique to 
each brain region. Lastly, using ACValidator, we in silico validate 45% of DE circRNAs 
as well as over 80% of the ones called by all tools in all the samples. 
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CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
1. Conclusions 
CircRNAs represent a newer area of research in transcriptomics and are a class of 
endogenous, non-coding RNAs that are formed when exons back-splice to each other. 
Since 2012, multiple circRNA studies have reported that they are pervasively expressed 
in eukaryotes, especially in the mammalian brain. While the functional role and impact of 
circRNAs remains to be clarified, they have been found to regulate miRNAs as well as 
parental gene transcription and might thus have key roles in transcriptional regulation. 
Although circRNAs have continued to gain attention, our understanding of their 
expression in a cell-, tissue- and brain region-specific context remains limited. Further, 
computational algorithms produce varied results in terms of the detected circRNAs. This 
thesis has attempted to address some of these gaps in circRNA research. 
We first used existing circRNA detection algorithms and identified circRNAs in 
RNAseq data previously generated from PC astrocytes microdissected from AD patients 
(N=10) and healthy elderly controls (N=10). In subsequent analyses, we predicted 
miRNA targets of circRNAs, and constructed regulatory circRNA-miRNA-mRNA 
networks using in silico methods. Notably, the widely reported CDR1as circRNA was 
predicted to have binding sites for 74 distinct miRNAs and 63 binding sites for miR-7. 
Pathway analysis of the genes regulated by these miRNAs identified significantly 
enriched immune response pathways, which is consistent with the known function of 
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astrocytes as immune sensors in the brain. While we did not detect recurrent differentially 
expressed circRNAs in the context of healthy  
controls or AD, we report for the first time circRNAs and their potential regulatory 
impact in a cell-specific and region-specific manner in aged subjects.  These predicted 
regulatory network and pathway analyses may help provide new insights into 
transcriptional regulation in the brain. 
Although available circRNA computational tools can identify circRNAs in 
RNAseq data, these tools do not capture the full length sequence of the circRNA and 
further, produce divergent results. We developed two novel bioinformatics approaches, 
DeFuCir and ACValidator to address these challenges. DeFuCir is an assembly based 
workflow for the characterization of full length circRNAs and that leverages soft-clipping 
signals in an alignment file. Though DeFuCir detects a smaller number of candidates, it 
achieves reasonable precision and can thus be used to complement existing approaches to 
filter for high confidence circRNAs and obtain their full length sequences. ACValidator 
is a novel bioinformatics workflow that can be used to validate candidate circRNAs of 
interest in silico and help distinguish true positive candidates. When different algorithms 
identify disparate circRNA candidates, ACValidator will be helpful in narrowing down 
specific circRNAs of interest to identify those associated with higher confidence. Further, 
this can also serve as a circRNA candidate selection tool for wet lab validations. 
ACValidator performs more optimally when a higher number of supporting reads are 
available and can be used for both RNAse R treated and non-treated samples. These two 
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novel assembly based approaches bring a new perspective to circRNA detection 
methodologies. 
Finally, we applied these two approaches, along with existing tools, to 
systematically characterize circRNA expression in five functionally distinct regions of 
healthy aged human brain – the BC, IP, MG, OC and SF. We also identified DE 
circRNAs in each region and their predicted impact on transcriptional networks. Genes 
from these networks were significantly enriched in nervous system developmental 
functions and pathways such as brain size and formation, development, morphology and 
proliferation of neurons, synaptic plasticity, proliferation of neuroglia and long-term 
potentiation. High confidence circRNAs, detected by both DeFuCir and existing 
approaches, map to RIMS1 in the BC, OC and SF, RIMS2 in the MG and MLIP in the IP. 
Further, we were able to in silico validate approximately 45% of DE circRNAs identified 
by DESeq2 and more than 80% of circRNAs called by all six tools in all samples.  
 
2. Limitations 
Although we were able to perform the aforementioned analyses, we are limited by 
a few caveats. In Chapter 2, the cell-specific transcriptomic data analyzed was not treated 
with RNAse R, and hence there is a larger pool of transcripts, majority of which are 
linear. As a result, we may not have efficiently captured astrocytic circRNAs in our 
samples. On the other hand, in Chapter 4, we use RNase R treatment to enrich for 
circRNAs in our samples. Although this treatment is essential in circRNA detection, it is 
not well understood if this depletion step introduces any biases in circRNA detection and 
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whether this step has the potential to deplete circRNAs. As we gain further insights into 
circRNA biology and their sensitivity/resistance to RNAse R, we may be able to tackle 
the problem of circRNA enrichment more efficiently. In Chapter 3, we were primarily 
limited by the lack of a gold standard circRNA reference dataset for evaluation of our 
approaches. As a result, we rely on simulation datasets, which are further based on 
informatically predicted circRNAs detected by various studies and deposited in circBase. 
Moreover, the small list of experimentally validated circRNAs from various studies (N = 
282) is derived from different cell and tissue types and hence may not be directly 
comparable to our datasets. In order to implement an unbiased, assembly based circRNA 
detection methodology, DeFuCir uses minimal filtering thresholds, and hence, repeat 
regions or single nucleotide variants (SNVs) in the region overlapping between the soft-
clipped portion and the lowest segment of a contig are currently not accounted for in our 
pipeline. These repeat regions may represent potential false positives and hence will be 
handled in the next version of the DeFuCir workflow using the RepeatMasker program 
[101]. This program and identify and mask repeated regions from analysis. Further, since 
our assembly analysis relies on overlapping read’s coverage over the regions of interest, 
we are limited in our ability to capture as well as in silico validate circRNAs whose 
abundance might be below detection levels in samples, particularly when they are not 
enriched for circRNAs.   
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3. Future Directions 
Whole transcriptome analysis is necessary for understanding how altered gene expression 
contributes to complex diseases such as AD and cancer. Recent revelations on a 
widespread number of coding and non-coding species of RNA enable a more 
comprehensive system level perspective of transcriptional regulation. Such understanding 
is needed to decipher the molecular underpinnings of basic cellular mechanisms as well 
as developing improved therapeutic strategies for rare and debilitating diseases. Moving 
toward this important goal, the next step of our research is to carry out whole 
transcriptome analysis of the brain region samples described in Chapter 4 by sequencing 
small RNAs, mRNAs, and long non-coding RNAs. Such analysis will both help 
characterize other RNA species as well as enable us to better evaluate the significance of 
circRNAs in the context of the whole transcriptome and its regulatory networks. 
Specifically, quantifying and comparing their expression will be performed to evaluate 
the abundance of each species relative to the whole transcriptome. Further, we will 
continue to develop DeFuCir and ACValidator as needed to account for new insights into 
circRNA biology. We will also include a module for handling repeat regions in the 
genome for DeFuCir in order to eliminate potential false positives.  
Given our identification of circRNAs that are unique and common across the 
brain regions we investigated, further functional studies on these candidates will help 
lend insights into their biological significance and clarify whether they truly represent an 
additional layer of transcriptional regulation in the brain. Additionally, comparing data 
from the current study with data from healthy younger individuals as well as affected 
   117 
elderly individuals will help us to understand whether they are specific to age or other 
conditions. Lastly, the workflows developed in this thesis are applicable to any non-
polyA selected RNAseq dataset and can thus be utilized to characterize circRNA 
expression across various sample types and diseases. 
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